cno-20240429
0001224608falsetrue00012246082024-04-292024-04-290001224608us-gaap:CommonStockMember2024-04-292024-04-290001224608cno:RightsToPurchaseSeriesFJuniorParticipatingPreferredStockMember2024-04-292024-04-290001224608cno:A5125SubordinatedDebenturesDue2060Member2024-04-292024-04-29


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): April 29, 2024

CNO Financial Group, Inc.
(Exact Name of Registrant as Specified in Charter)
 
Delaware001-3179275-3108137
(State or Other
Jurisdiction of Incorporation)		(Commission File Number)(I.R.S. Employer
Identification No.)
11299 Illinois Street
Carmel, Indiana  46032
(Address of Principal Executive Offices) (Zip Code)

(317) 817-6100
(Registrant's telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, par value $0.01 per shareCNONew York Stock Exchange
Rights to purchase Series F Junior Participating Preferred StockNew York Stock Exchange
5.125% Subordinated Debentures due 2060CNOpANew York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 2.02.Results of Operations and Financial Condition.

On April 29, 2024, CNO Financial Group, Inc. ("CNO" or the "Company") issued: (i) a press release announcing its financial results for the quarter ended March 31, 2024, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference; (ii) the Quarterly Financial Supplement for March 31, 2024, a copy of which is attached hereto as Exhibit 99.2 and is incorporated herein by reference; and (iii) additional financial information related to its financial and operating results for the quarter ended March 31, 2024, a copy of which is attached hereto as Exhibit 99.3 and is incorporated herein by reference.

The information contained under Item 2.02 in this Current Report on Form 8-K (including Exhibits 99.1, 99.2 and 99.3) is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section. The information contained in this Current Report on Form 8-K shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.


Item 9.01(d).Financial Statements and Exhibits.

The following materials are furnished as exhibits to this Current Report on Form 8-K:

99.1
99.2
99.3
104Cover Page Interactive Data File (embedded within the Inline XBRL document).





2



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CNO Financial Group, Inc.
Date: April 29, 2024
By:/s/ Michellen A. Wildin
Michellen A. Wildin
Senior Vice President and
Chief Accounting Officer




3

Exhibit 99.1
                            News

For Immediate Release


CNO Financial Group Reports First Quarter 2024 Results
Strong sales and distribution force growth; Total new annualized premiums up 8%;
Solid first quarter earnings

Carmel, Ind., April 29, 2024 - CNO Financial Group, Inc. (NYSE: CNO) today reported net income of $112.3 million, or $1.01 per diluted share, in 1Q24 compared to a net loss of $0.8 million, or $0.01 per diluted share, in 1Q23. Net operating income (1) was $57.5 million, or $0.52 per diluted share, in 1Q24 compared to $58.6 million, or $0.51 per diluted share, in 1Q23.

"First quarter results were among the best operating metrics we’ve delivered in the past several years with respect to Consumer and Worksite sales, our distribution force and new products," said Gary C. Bhojwani, chief executive officer.

"Operating earnings benefited from growth in insurance product margins, reflecting recent sales momentum and expansion of the portfolio yield on five quarters of new money rates exceeding 6%. The only material item that offset our strong operating results in the quarter was $24.3 million of unfavorable mark-to-market pre-tax impacts on real estate partnerships within our alternative investment portfolio. These assets are delivering stable cash flows; however, the economic environment is pressuring their market values. Despite these impacts, total net investment income was up in the quarter."

"Our financial health remains strong, as shown by our excellent capital position and growth in book value per diluted share. We remain focused on serving the needs of middle-income consumers and delivering sustainable profitable growth for our shareholders."

First Quarter 2024 Highlights (as compared to the corresponding period in the prior year where applicable)
•    Consumer Division new annualized premiums ("NAP") (4) up 7% and producing agent count up 8%

•Worksite Division NAP up 19% and producing agent count up 28%

•Medicare Supplement NAP up 24%, Medicare Advantage policies sold up 38%

•     Returned $57.3 million to shareholders

•     Book value per share was $21.81; book value per diluted share, excluding accumulated other comprehensive loss, (2) was $34.97

•     Return on equity ("ROE") of 18.8%; operating ROE, as adjusted, (5) of 9.7%

•Full year guidance remains unchanged




FINANCIAL SUMMARY
Quarter End
(Amounts in millions, except per share data)
(Unaudited)

Net operating income, a non-GAAP(a) financial measure, is used consistently by CNO’s management to evaluate the operating performance of the Company and is a measure commonly used in the life insurance industry. It differs from net income primarily because it excludes certain non-operating items such as net realized investment gains (losses) from sales and change in the allowance for credit losses, changes in fair values of embedded derivatives and market risk benefits and the liability for a deferred compensation plan, and certain significant and unusual items included in net income. Management believes an analysis of net operating income is important in understanding the profitability and operating trends of the Company’s business. Net income is the most directly comparable GAAP measure.

Per diluted share
Quarter endedQuarter ended
March 31,March 31,
20242023% change20242023% change
Income from insurance products (b)
$0.61 $0.56 9 $68.0 $63.7 7 
Fee income0.10 0.13 (23)11.3 15.5 (27)
Investment income not allocated to product lines (c)
0.11 0.14 (21)12.3 15.5 (21)
Expenses not allocated to product lines(0.15)(0.16)(6)(16.8)(18.3)(8)
Operating earnings before taxes0.67 0.67 74.8 76.4 
Income tax expense on operating income(0.15)(0.16)(6)(17.3)(17.8)(3)
Net operating income (1)0.52 0.51 2 57.5 58.6 (2)
Net realized investment losses from sales and change in allowance for credit losses(0.04)(0.11)(4.6)(12.7)
Net change in market value of investments recognized in earnings0.11 (0.02)12.4 (1.9)
Changes in fair value of embedded derivative liabilities and market risk benefits0.57 (0.57)64.0 (65.1)
Other— 0.02 (0.4)2.3 
Non-operating income (loss) before taxes0.64 (0.68)71.4 (77.4)
Income tax (expense) benefit on non-operating income (loss)(0.15)0.16 (16.6)18.0 
Net non-operating income (loss)0.49 (0.52)54.8 (59.4)
Net income (loss)$1.01 $(0.01)$112.3 $(0.8)
Weighted average diluted shares outstanding110.8 114.5 

____________________
(a)    GAAP is defined as accounting principles generally accepted in the United States of America.
(b)    Income from insurance products is the sum of the insurance margins of the annuity, health and life product lines, less expenses allocated to the insurance product lines. It excludes the income from our fee income business, investment income not allocated to product lines, net expenses not allocated to product lines (primarily holding company expenses) and income taxes. Insurance margin is management’s measure of the profitability of its annuity, health and life segments’ performance and consists of insurance policy income plus allocated investment income less insurance policy benefits, interest credited, commissions, advertising expense and amortization of acquisition costs.
(c)    Investment income not allocated to product lines represents net investment income less: (i) equity returns credited to policyholder account balances; (ii) the investment income allocated to our product lines; (iii) interest expense on notes payable, investment borrowings and financing arrangements; (iv) expenses related to the funding agreement-backed notes ("FABN") program; and (v) certain expenses related to benefit plans that are offset by special-purpose investment income; plus (vi) the impact of annual option forfeitures related to fixed indexed annuity surrenders.

2

FINANCIAL SUMMARY (continued)
Management vs. GAAP Measures
(Dollars in millions, except per share data)
(Unaudited)

Shareholders’ equity, excluding accumulated other comprehensive income (loss), and book value per share, excluding accumulated other comprehensive income (loss), are non-GAAP measures that are utilized by management to view the business without the effect of accumulated other comprehensive income (loss) which is primarily attributable to fluctuations in interest rates associated with fixed maturities, available for sale. Management views the business in this manner because the Company has the ability and generally, the intent, to hold investments to maturity and meaningful trends can be more easily identified without the fluctuations. In addition, shareholders' equity excludes net operating loss carryforwards in our non-GAAP return on equity measures as such assets are not discounted and, accordingly, will not provide a return to shareholders until after it is realized as a reduction to taxes that would otherwise be paid. Management believes that excluding this value from the equity component of this measure enhances the understanding of the effect these non-discounted assets have on operating returns.
___________________________________________________________________________________________________

Quarter ended
March 31,
20242023
Trailing twelve months return on equity (a)
18.8 %21.8 %
Trailing twelve months operating return on equity, excluding accumulated other comprehensive income (loss) and net operating loss carryforwards (a non-GAAP financial measure) (5)
9.7 %10.3 %
Trailing twelve months operating return, excluding significant items, on equity, excluding accumulated other comprehensive income (loss) and net operating loss carryforwards (a non-GAAP financial measure) (5)
8.5 %9.8 %
Shareholders’ equity$2,367.7 $2,031.8 
Accumulated other comprehensive loss1,480.3 1,664.4 
Shareholders’ equity, excluding accumulated other comprehensive loss3,848.0 3,696.2 
Net operating loss carryforwards(311.2)(152.4)
Shareholders' equity, excluding accumulated other comprehensive loss and net operating loss carryforwards$3,536.8 $3,543.8 
Book value per diluted share$21.52 $17.49 
Accumulated other comprehensive loss13.45 14.33 
Book value per diluted share, excluding accumulated other comprehensive loss (a non-GAAP financial measure) (2)
$34.97 $31.82 

____________________
(a) Calculated using average shareholders’ equity for the measurement period.







3

Non-Operating Items
Net investment losses in 1Q24 were $4.6 million net of a reduction in the allowance for credit losses of $1.5 million. Net investment losses in 1Q23 were $12.7 million including an increase in the allowance for credit losses of $1.5 million.

During 1Q24 and 1Q23, we recognized an increase (decrease) in earnings of $12.4 million and $(1.9) million, respectively, due to the net change in market value of investments.

During 1Q24 and 1Q23, we recognized an increase (decrease) in earnings of $64.0 million and $(65.1) million, respectively, resulting from changes in the estimated fair value of embedded derivative liabilities and market risk benefits related to our fixed indexed annuities. Such amounts include the impacts of changes in market interest rates and equity impacts used to determine the estimated fair values of the embedded derivatives and market risk benefits.

INVESTMENT PORTFOLIO
(Dollars in millions)



Fixed maturities, available for sale, at amortized cost by asset class as of March 31, 2024 are as follows:
Investment gradeBelow investment gradeTotal
Corporate securities$12,557.8 $574.9 $13,132.7 
United States Treasury securities and obligations of the United States government and agencies232.8 — 232.8 
States and political subdivisions3,044.9 9.6 3,054.5 
Foreign governments94.8 — 94.8 
Asset-backed securities1,436.8 109.3 1,546.1 
Agency residential mortgage-backed securities683.3 — 683.3 
Non-agency residential mortgage-backed securities1,189.0 481.4 (a)1,670.4 
Collateralized loan obligations1,151.0 — 1,151.0 
Commercial mortgage-backed securities2,296.7 88.5 2,385.2 
Total$22,687.1 $1,263.7 $23,950.8 

____________________
(a)     Certain structured securities rated below investment grade by Nationally Recognized Statistical Rating Organizations may be assigned a NAIC 1 or NAIC 2 designation based on the cost basis of the security relative to estimated recoverable amounts as determined by the National Association of Insurance Commissioners (NAIC).

The fair value of CNO’s available for sale fixed maturity portfolio was $21.6 billion compared with an amortized cost of $24.0 billion. Net unrealized losses were comprised of gross unrealized gains of $127.5 million and gross unrealized losses of $2,391.2 million. The allowance for credit losses was $39.0 million at March 31, 2024.

Statutory (based on non-GAAP measures) and GAAP Capital Information
The consolidated statutory risk-based capital ratio of our U.S. based insurance subsidiaries was estimated at 391% at March 31, 2024, reflecting an estimated 1Q24 statutory operating loss of $4 million and the payment of insurance company dividends (net of capital contributions) to the holding company of $43.3 million during 1Q24.

During 1Q24, we repurchased $40.0 million of common stock under our securities repurchase program (including $0.8 million of repurchases settled in 2Q24). We repurchased 1.5 million common shares at an average cost of $26.98 per share. As of March 31, 2024, we had 108.6 million shares outstanding and had authority to repurchase up to an additional $481.8 million of our common stock. During 1Q24, dividends paid on common stock totaled $17.3 million.

Unrestricted cash and investments held by our holding company were $223 million at March 31, 2024, compared to $256 million at December 31, 2023.

Book value per common share was $21.81 at March 31, 2024 compared to $20.26 at December 31, 2023. Book value per diluted share, excluding accumulated other comprehensive income (loss) (2), was $34.97 at March 31, 2024, compared to $33.94 at December 31, 2023.

4

The debt-to-capital ratio was 32.5% and 34.0% at March 31, 2024 and December 31, 2023, respectively. Our debt-to-total capital ratio, excluding accumulated other comprehensive income (loss) (3) was 22.9% and 23.1% at March 31, 2024 and December 31, 2023, respectively.

Return on equity for the trailing four quarters ended March 31, 2024 and 2023, was 18.8% and 21.8%, respectively. Operating return, excluding significant items, on equity, excluding accumulated other comprehensive income (loss) and net operating loss carryforwards (5) for the trailing four quarters ended March 31, 2024 and 2023, was 8.5% and 9.8%, respectively.

In this news release, CNO includes non-GAAP measures to enhance investors’ understanding of management’s view of the business. The non-GAAP measures are not a substitute for GAAP, but rather a supplement to increase transparency by providing a broader perspective. CNO’s definitions of non-GAAP measures may differ from other companies’ definitions. More detailed information including various GAAP and non-GAAP measurements are located at CNOinc.com in the Investors section under SEC Filings.


CAUTION REGARDING FORWARD-LOOKING STATEMENTS:

This press release may contain forward-looking statements within the meaning of federal securities laws. These prospective statements reflect management’s current expectations, but are not guarantees of future performance. Accordingly, please refer to CNO’s cautionary statement regarding forward-looking statements, and the business environment in which the Company operates, contained in the Company’s Form 10-K for the year ended December 31, 2023 and any subsequent Form 10-Q or Form 10-K on file with the Securities and Exchange Commission and on the Company’s website at CNOinc.com in the Investors section.  CNO specifically disclaims any obligation to update or revise any forward-looking statement because of new information, future developments or otherwise.


EARNINGS RELEASE CONFERENCE CALL WEBCAST:

The Company will host a conference call to discuss results on April 30, 2024 at 11:00 a.m. Eastern Time. During the call, we will be referring to a presentation that will be available at the Investors section of the company's website.

To participate by dial-in, please register at https://www.netroadshow.com/events/login?show=1fa894a1&confId=64047. Upon registering, you will be provided with call details and a registrant ID used to track attendance on the conference call. Reminders will also be sent to registered participants via email.

For those investors who prefer to listen to the call online, we will be broadcasting the call live via webcast. The event can be accessed through the Investors section of the company's website: ir.CNOinc.com. Participants should go to the website at least 15 minutes before the event to register and download any necessary audio software.


ABOUT CNO FINANCIAL GROUP

CNO Financial Group, Inc. (NYSE: CNO) secures the future of middle-income America. CNO provides life and health insurance, annuities, financial services, and workforce benefits solutions through our family of brands, including Bankers Life, Colonial Penn, Optavise and Washington National. Our customers work hard to save for the future, and we help protect their health, income, and retirement needs with 3.2 million policies and $35 billion in total assets. Our 3,500 associates, 4,700 exclusive agents and more than 5,000 independent partner agents guide individuals, families, and businesses through a lifetime of financial decisions. For more information, visit CNOinc.com.
5

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEET
(Dollars in millions)
(unaudited)

March 31,
2024		December 31,
2023
ASSETS
Investments:
Fixed maturities, available for sale, at fair value (net of allowance for credit losses: March 31, 2024 - $39.0 and December 31, 2023 - $42.9; amortized cost: March 31, 2024 - $23,950.8 and December 31, 2023 - $23,699.2)$21,648.1 $21,506.2 
Equity securities at fair value118.4 96.9 
Mortgage loans (net of allowance for credit losses: March 31, 2024 - $16.6 and December 31, 2023 - $15.4)2,087.1 2,064.1 
Policy loans130.3 128.5 
Trading securities222.8 222.7 
Investments held by variable interest entities (net of allowance for credit losses: March 31, 2024 - $4.3 and December 31, 2023 - $3.1; amortized cost: March 31, 2024 - $547.2 and December 31, 2023 - $787.6)533.4 768.6 
Other invested assets1,471.3 1,353.4 
Total investments26,211.4 26,140.4 
Cash and cash equivalents - unrestricted566.3 774.5 
Cash and cash equivalents held by variable interest entities83.5 114.5 
Accrued investment income252.0 251.5 
Present value of future profits175.5 180.7 
Deferred acquisition costs1,992.3 1,944.4 
Reinsurance receivables (net of allowance for credit losses: March 31, 2024 - $3.0 and December 31, 2023 - $3.0)3,969.0 4,040.7 
Market risk benefit asset84.1 75.4 
Income tax assets, net886.1 936.2 
Assets held in separate accounts3.3 3.1 
Other assets716.2 641.1 
Total assets$34,939.7 $35,102.5 
LIABILITIES AND SHAREHOLDERS' EQUITY
Liabilities: 
Liabilities for insurance products: 
Policyholder account balances$15,736.7 $15,667.8 
Future policy benefits11,736.5 11,928.2 
Market risk benefit liability3.8 7.4 
Liability for life insurance policy claims65.1 62.1 
Unearned and advanced premiums226.0 218.9 
Liabilities related to separate accounts3.3 3.1 
Other liabilities905.0 848.8 
Investment borrowings2,189.1 2,189.3 
Borrowings related to variable interest entities565.5 820.8 
Notes payable – direct corporate obligations1,141.0 1,140.5 
Total liabilities32,572.0 32,886.9 
Commitments and Contingencies
Shareholders' equity:
Common stock ($0.01 par value, 8,000,000,000 shares authorized, shares issued and outstanding: March 31, 2024 – 108,568,594; December 31, 2023 – 109,357,540)1.1 1.1 
Additional paid-in capital1,851.2 1,891.5 
Accumulated other comprehensive loss(1,480.3)(1,576.8)
Retained earnings1,995.7 1,899.8 
Total shareholders' equity2,367.7 2,215.6 
Total liabilities and shareholders' equity$34,939.7 $35,102.5 

6

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENT OF OPERATIONS
(Dollars in millions, except per share data)
(unaudited)
Three months ended
March 31,
 20242023
Revenues:  
Insurance policy income$628.4 $625.5 
Net investment income:
General account assets301.9 292.2 
Policyholder and other special-purpose portfolios167.3 50.8 
Investment gains (losses):
Realized investment losses(10.0)(14.6)
Other investment gains17.8 — 
Total investment gains (losses)7.8 (14.6)
Fee revenue and other income51.1 52.1 
Total revenues1,156.5 1,006.0 
Benefits and expenses:  
Insurance policy benefits631.4 609.7 
Liability for future policy benefits remeasurement loss(6.4).6 
Change in fair value of market risk benefits(13.7)14.8 
Interest expense60.2 54.7 
Amortization of deferred acquisition costs and present value of future profits 60.5 55.5 
Other operating costs and expenses278.3 271.7 
Total benefits and expenses1,010.3 1,007.0 
Income (loss) before income taxes146.2 (1.0)
Income tax expense (benefit) on period income (loss)33.9 (0.2)
Net income (loss)$112.3 $(0.8)
Earnings per common share:  
Basic:  
Weighted average shares outstanding108,964,000 114,545,000 
Net income (loss)$1.03 $(.01)
Diluted:
Weighted average shares outstanding110,845,000 114,545,000 
Net income (loss)$1.01 $(.01)


7

NOTES
(1)Management believes that an analysis of Net income applicable to common stock before: (i) net realized investment gains or losses from sales, impairments and the change in allowance for credit losses, net of taxes; (ii) net change in market value of investments recognized in earnings, net of taxes; (iii) changes in fair value of embedded derivative liabilities and market risk benefits related to our fixed indexed annuities, net of taxes; (iv) fair value changes related to the agent deferred compensation plan, net of taxes; (v) loss related to reinsurance transaction, net of taxes; (vi) loss on extinguishment of debt, net of taxes; (vii) changes in the valuation allowance for deferred tax assets and other tax items; and (viii) other non-operating items consisting primarily of earnings attributable to variable interest entities, net of taxes ("Net operating income," a non-GAAP financial measure) is important to evaluate the financial performance of the company, and is a key measure commonly used in the life insurance industry. Management uses this measure to evaluate performance because the items excluded from net operating income can be affected by events that are unrelated to the company's underlying fundamentals. A reconciliation of Net operating income to Net income applicable to common stock is provided in the table on page 2. Additional information concerning this non-GAAP measure is included in our periodic filings with the Securities and Exchange Commission that are available in the "Investors - SEC Filings" section of CNO's website, CNOinc.com.
(2)Book value per diluted share reflects the potential dilution that could occur if outstanding stock options were exercised and restricted stock and performance units were vested. The dilution from options, restricted shares and performance units is calculated using the treasury stock method. Under this method, we assume the proceeds from the exercise of the options (or the unrecognized compensation expense with respect to restricted stock and performance units) will be used to purchase shares of our common stock at the closing market price on the last day of the period. In addition, the calculation of this non-GAAP measure differs from the corresponding GAAP measure because accumulated other comprehensive income (loss) has been excluded from the value of capital used to determine this measure. Management believes this non-GAAP measure is useful because it removes the volatility that arises from changes in the unrealized appreciation (depreciation) of our investments.
(3)The calculation of this non-GAAP measure differs from the corresponding GAAP measure because accumulated other comprehensive income (loss) has been excluded from the value of capital used to determine this measure. Management believes this non-GAAP measure is useful because it removes the volatility that arises from changes in the unrealized appreciation (depreciation) of our investments.
(4)Measured by new annualized premiums for life and health products, which includes 10% of single premium whole life deposits and 100% of all other premiums (excluding annuities). Sales of third-party products are excluded.
(5)The following summarizes the calculations of: (i) operating return on equity, excluding accumulated other comprehensive income (loss) and net operating loss carryforwards (a non-GAAP financial measure); (ii) operating return, excluding significant items, on equity, excluding accumulated other comprehensive income (loss) and net operating loss carryforwards (a non-GAAP financial measure); and (iii) return on equity are as follows (dollars in millions):
Trailing twelve months ended
1Q241Q23
Net operating income$355.0 $354.5 
Net operating income, excluding significant items$311.7 $336.6 
Net income$389.6 $446.4 
Average common equity, excluding accumulated other
comprehensive income (loss) and net operating loss
carryforwards (a non-GAAP financial measure)$3,650.0 $3,434.8 
Average common shareholders' equity$2,075.3 $2,046.3 
Operating return on equity, excluding accumulated other
comprehensive income (loss) and net operating loss
carryforwards (a non-GAAP financial measure)9.7 %10.3 %
Operating return, excluding significant items, on equity, excluding
accumulated other comprehensive income (loss) and net
operating loss carryforwards (a non-GAAP financial measure)8.5 %9.8 %
Return on equity18.8 %21.8 %


8

The following summarizes: (i) net operating income; (ii) significant items; (iii) net operating income, excluding significant items; and (iv) net income (loss) (dollars in millions):
Net operating
Net operatingincome,
income,excludingNet
excludingsignificantincome -
Net operatingSignificantsignificantitems - trailingNettrailing
incomeitemsitems (a)four quartersincome (loss)four quarters
2Q22$135.1 $(17.4)(b)$117.7 $393.4 $233.3 $677.3 
3Q2277.9 — 77.9 360.9 175.9 749.8 
4Q2282.9 (0.5)(c)82.4 342.5 38.0 630.6 
1Q2358.6 — 58.6 336.6 (0.8)446.4 
2Q2362.3 — 62.3 281.2 73.7 286.8 
3Q23101.3 (16.9)(d)84.4 287.7 167.3 278.2 
4Q23133.9 (26.4)(e)107.5 312.8 36.3 276.5 
1Q2457.5 — 57.5 311.7 112.3 389.6 
(a) See note (6) for additional information.
(b) Comprised of an experience refund of $22.5 million related to a reinsurance agreement, net of tax expense of $5.1 million.
(c) Comprised of $.7 million of the net favorable impact arising from our comprehensive annual actuarial review, net of tax expense of $.2 million.
(d) Comprised of $21.7 million of legal recoveries, net of expenses and increased legal accruals, net of tax expense of $4.8 million.
(e) Comprised of $33.9 million of the net favorable impact arising from our comprehensive annual actuarial review, net of tax expense of $7.5 million.

A reconciliation of pre-tax operating earnings (a non-GAAP financial measure) to net income is as follows (dollars in millions):
Twelve months ended
1Q241Q23
Pre-tax operating earnings (a non-GAAP financial measure)$457.9 $458.6 
Income tax expense(102.9)(104.1)
Net operating income355.0 354.5 
Non-operating items:
Net realized investment losses from sales, impairments and change in allowance for credit losses(54.6)(67.7)
Net change in market value of investments recognized in earnings8.0 (49.6)
Changes in fair value of embedded derivative liabilities and market risk benefits99.2 209.7 
Fair value changes related to the agent deferred compensation plan(3.5)26.2 
Other(3.0)(2.0)
Non-operating income before taxes46.1 116.6 
    Income tax expense on non-operating income(11.5)(24.7)
Net non-operating income34.6 91.9 
Net income$389.6 $446.4 
9

A reconciliation of consolidated capital, excluding accumulated other comprehensive income (loss) and net operating loss carryforwards (a non-GAAP financial measure) to common shareholders’ equity, is as follows (dollars in millions):

1Q222Q223Q224Q22
Consolidated capital, excluding accumulated other comprehensive
income (loss) and net operating loss carryforwards
(a non-GAAP financial measure)$3,141.7 $3,329.0 $3,510.3 $3,557.1 
Net operating loss carryforwards238.2 214.7 190.9 169.0 
Accumulated other comprehensive loss(561.5)(1,415.8)(1,837.8)(1,957.3)
Common shareholders' equity$2,818.4 $2,127.9 $1,863.4 $1,768.8 
1Q232Q233Q234Q24
Consolidated capital, excluding accumulated other comprehensive
income (loss) and net operating loss carryforwards
(a non-GAAP financial measure)$3,543.8 $3,603.0 $3,744.2 $3,712.8 
Net operating loss carryforwards152.4 126.3 102.6 79.6 
Accumulated other comprehensive loss(1,664.4)(1,733.5)(1,956.7)(1,576.8)
Common shareholders' equity$2,031.8 $1,995.8 $1,890.1 $2,215.6 
1Q24
Consolidated capital, excluding accumulated other comprehensive
income (loss) and net operating loss carryforwards
(a non-GAAP financial measure)$3,536.8 
Net operating loss carryforwards311.2 
Accumulated other comprehensive loss(1,480.3)
Common shareholders' equity$2,367.7 

A reconciliation of consolidated capital, excluding accumulated other comprehensive income (loss) and net operating loss carryforwards (a non-GAAP financial measure) to common shareholders’ equity, is as follows (dollars in millions):
Trailing four quarter average
1Q241Q23
Consolidated capital, excluding accumulated other comprehensive
income (loss) and net operating loss carryforwards
(a non-GAAP financial measure)$3,650.0 $3,434.8 
Net operating loss carryforwards135.1 192.5 
Accumulated other comprehensive loss(1,709.8)(1,581.0)
Common shareholders' equity$2,075.3 $2,046.3 


10

(6)    The tables below summarize the financial impact of significant items on our net operating income. Management believes that identifying the impact of these items enhances the understanding of our operating results (dollars in millions, except per share data).
Three months ended
December 31, 2023
Actual resultsSignificant itemsExcluding significant
items
Insurance product margin
Annuity margin$63.6 $(12.9)(a)$50.7 
Health margin146.4 (22.3)(a)124.1 
Life margin64.6 1.3 (a)65.9 
Total insurance product margin274.6 (33.9)240.7 
Allocated expenses(138.8)— (138.8)
Income from insurance products135.8 (33.9)101.9 
Fee income17.8 — 17.8 
Investment income not allocated to product lines38.3 — 38.3 
Expenses not allocated to product lines(19.8)— (19.8)
Operating earnings before taxes172.1 (33.9)138.2 
Income tax (expense) benefit on operating income(38.2)7.5 (30.7)
Net operating income$133.9 $(26.4)$107.5 
Net operating income per diluted share$1.18 $(0.23)$0.95 
___________
(a)Comprised of $33.9 million of the net favorable impact arising from our comprehensive annual actuarial review.

Three months ended
September 30, 2023
Actual resultsSignificant itemsExcluding significant
items
Insurance product margin
Annuity margin$57.0 $— $57.0 
Health margin123.2 — 123.2 
Life margin59.8 — 59.8 
Total insurance product margin240.0 — 240.0 
Allocated expenses(153.2)— (153.2)
Income from insurance products86.8 — 86.8 
Fee income(2.9)— (2.9)
Investment income not allocated to product lines38.4 — 38.4 
Expenses not allocated to product lines7.5 (21.7)(a)(14.2)
Operating earnings before taxes129.8 (21.7)108.1 
Income tax (expense) benefit on operating income(28.5)4.8 (23.7)
Net operating income$101.3 $(16.9)$84.4 
Net operating income per diluted share$0.88 $(0.14)$0.74 
___________
(a)Comprised of $21.7 million of legal recoveries, net of expenses and increased legal accruals.

11

Three months ended
December 31, 2022
Actual resultsSignificant itemsExcluding significant
items
Insurance product margin
Annuity margin$50.8 $3.2 (a)$54.0 
Health margin140.4 (18.3)(a)122.1 
Life margin43.3 14.4 (a)57.7 
Total insurance product margin234.5 (0.7)233.8 
Allocated expenses(149.1)— (149.1)
Income from insurance products85.4 (0.7)84.7 
Fee income9.2 — 9.2 
Investment income not allocated to product lines25.2 — 25.2 
Expenses not allocated to product lines(12.8)— (12.8)
Operating earnings before taxes107.0 (0.7)106.3 
Income tax (expense) benefit on operating income(24.1)0.2 (23.9)
Net operating income$82.9 $(0.5)$82.4 
Net operating income per diluted share$0.71 $— $0.71 
___________
(a)Comprised of $0.7 million of the net favorable impact arising from our comprehensive annual actuarial review.

Three months ended
June 30, 2022
Actual resultsSignificant itemsExcluding significant
items
Insurance product margin
Annuity margin$60.1 $— $60.1 
Health margin125.4 — 125.4 
Life margin70.2 — 70.2 
Total insurance product margin255.7 — 255.7 
Allocated expenses(152.2)— (152.2)
Income from insurance products103.5 — 103.5 
Fee income3.2 — 3.2 
Investment income not allocated to product lines64.6 — 64.6 
Expenses not allocated to product lines2.9 (22.5)(a)(19.6)
Operating earnings before taxes174.2 (22.5)151.7 
Income tax (expense) benefit on operating income(39.1)5.1 (34.0)
Net operating income$135.1 $(17.4)$117.7 
Net operating income per diluted share$1.15 $(0.15)$1.00 
___________
(a)Comprised of an experience refund of $22.5 million related to a reinsurance agreement.




For further information:

CNO News Media
Valerie Dolenga
[email protected]

CNO Investor Relations
Adam Auvil
[email protected]
12

Exhibit 99.2






Quarterly Financial Supplement - 1Q2024
April 29, 2024

Page 1

Table of ContentsPage
Consolidated balance sheet3
Consolidated statement of operations4
Financial summary5
Insurance operations6
Margin from insurance products7-9
Collected premiums and insurance policy income10
Health and life new annualized premiums11
Computation of weighted average shares outstanding12
Annuities - account value rollforwards13
Consolidated statutory information of U.S. based insurance subsidiaries14
Investment income not allocated to product lines and investment income allocated to product lines15-18
Other investment data18
Significant items19-20
Notes21-22

Page 2

CNO FINANCIAL GROUP, INC.
CONSOLIDATED BALANCE SHEET
(Dollars in millions)
(Unaudited)
Mar-23Jun-23Sep-23Dec-23Mar-24
Assets
Investments:
  Fixed maturities, available for sale, at fair value$21,107.1 $20,959.7 $20,305.2 $21,506.2 $21,648.1 
  Equity securities at fair value106.1 96.4 95.5 96.9 118.4 
  Mortgage loans1,676.1 1,825.9 1,971.3 2,064.1 2,087.1 
  Policy loans123.0 124.2 126.4 128.5 130.3 
  Trading securities208.1 218.9 221.2 222.7 222.8 
  Investments held by variable interest entities1,017.9 948.2 858.1 768.6 533.4 
  Other invested assets1,097.1 1,176.7 1,119.9 1,353.4 1,471.3 
  Total investments25,335.4 25,350.0 24,697.6 26,140.4 26,211.4 
Cash and cash equivalents - unrestricted425.0 457.7 460.8 774.5 566.3 
Cash and cash equivalents held by variable interest entities97.1 104.2 122.0 114.5 83.5 
Accrued investment income241.3 242.1 252.3 251.5 252.0 
Present value of future profits197.6 191.8 186.2 180.7 175.5 
Deferred acquisition costs1,811.3 1,857.7 1,897.5 1,944.4 1,992.3 
Reinsurance receivables4,189.6 4,029.2 4,053.2 4,040.7 3,969.0 
Market risk benefit asset57.8 66.0 89.3 75.4 84.1 
Income tax assets, net988.1 1,007.1 1,039.8 936.2 886.1 
Assets held in separate accounts2.8 3.0 2.9 3.1 3.3 
Other assets669.0 745.1 705.8 641.1 716.2 
Total assets$34,015.0 $34,053.9 $33,507.4 $35,102.5 $34,939.7 
Liabilities
Liabilities for insurance products:
  Policyholder account balances$15,302.9 $15,387.7 $15,481.8 $15,667.8 $15,736.7 
  Future policy benefits11,623.3 11,479.6 10,829.9 11,928.2 11,736.5 
  Market risk benefit liability17.6 10.5 3.1 7.4 3.8 
  Liability for life insurance policy claims67.6 64.6 60.8 62.1 65.1 
  Unearned and advanced premiums243.5 233.6 221.2 218.9 226.0 
  Liabilities related to separate accounts2.8 3.0 2.9 3.1 3.3 
Other liabilities681.3 898.9 869.6 848.8 905.0 
Investment borrowings1,839.6 1,839.5 2,089.4 2,189.3 2,189.1 
Borrowings related to variable interest entities1,065.4 1,001.0 918.5 820.8 565.5 
Notes payable - direct corporate obligations1,139.2 1,139.7 1,140.1 1,140.5 1,141.0 
Total liabilities31,983.2 32,058.1 31,617.3 32,886.9 32,572.0 
Shareholders' equity
Common stock1.1 1.1 1.1 1.1 1.1 
Additional paid-in capital2,021.1 1,997.9 1,965.3 1,891.5 1,851.2 
Retained earnings1,674.0 1,730.3 1,880.4 1,899.8 1,995.7 
Total shareholders' equity before accumulated other comprehensive loss3,696.2 3,729.3 3,846.8 3,792.4 3,848.0 
Accumulated other comprehensive loss(1,664.4)(1,733.5)(1,956.7)(1,576.8)(1,480.3)
Total shareholders' equity2,031.8 1,995.8 1,890.1 2,215.6 2,367.7 
Total liabilities and shareholders' equity$34,015.0 $34,053.9 $33,507.4 $35,102.5 $34,939.7 
Mar-23Jun-23Sep-23Dec-23Mar-24
Book value per common share$17.68 $17.56 $16.85 $20.26 $21.81 
Book value per common share, excluding accumulated other comprehensive loss (1) (2)$32.17 $32.81 $34.30 $34.68 $35.44 
Book value per diluted share (1) (3)$31.82 $32.34 $33.75 $33.94 $34.97 
Page 3

CNO FINANCIAL GROUP, INC.
CONSOLIDATED STATEMENT OF OPERATIONS
(Dollars in millions)
(Unaudited)

1Q2Q3Q4QYTD1Q
202320232023202320232024
Revenues
Insurance policy income$625.5 $628.3 $626.0 $625.7 $2,505.5 $628.4 
Net investment income:
   General account assets292.2 308.1 324.8 325.1 1,250.2 301.9 
Policyholder and other special-purpose portfolios50.8 91.6 (33.0)140.1 249.5 167.3 
Investment gains (losses):
Realized investment losses(14.6)(21.8)(21.6)(11.3)(69.3)(10.0)
Other investment gains (losses)— (13.5)(7.7)21.5 0.3 17.8 
Total investment gains (losses)(14.6)(35.3)(29.3)10.2 (69.0)7.8 
Fee revenue and other income52.1 30.1 59.0 69.4 210.6 51.1 
Total revenues1,006.0 1,022.8 947.5 1,170.5 4,146.8 1,156.5 
Benefits and expenses
Insurance policy benefits609.7 565.9 399.1 743.5 2,318.2 631.4 
Liability for future policy benefits remeasurement (gain) loss0.6 8.3 (0.1)(30.0)(21.2)(6.4)
Change in fair value of market risk benefits14.8 (17.6)(33.8)15.3 (21.3)(13.7)
Interest expense54.7 57.6 62.6 63.7 238.6 60.2 
Amortization of deferred acquisition costs and present value of future profits 55.5 56.0 57.0 58.9 227.4 60.5 
Other operating costs and expenses271.7 256.5 247.1 273.0 1,048.3 278.3 
Total benefits and expenses1,007.0 926.7 731.9 1,124.4 3,790.0 1,010.3 
Income (loss) before income taxes(1.0)96.1 215.6 46.1 356.8 146.2 
Income tax expense (benefit) on period income (loss)(0.2)22.4 48.3 9.8 80.3 33.9 
Net income (loss)$(0.8)$73.7 $167.3 $36.3 $276.5 $112.3 


Page 4

CNO FINANCIAL GROUP, INC.
FINANCIAL SUMMARY
(Dollars in millions, except per share data)
(Unaudited)

1Q2Q3Q4QYTD1Q
202320232023202320232024
Insurance product margin (4)
Annuity margin$57.3 $57.1 $57.0 $63.6 $235.0 $52.0 
Health margin116.5 108.2 123.2 146.4 494.3 123.0 
Life margin47.4 57.9 59.8 64.6 229.7 54.6 
Total insurance product margin221.2 223.2 240.0 274.6 959.0 229.6 
Allocated expenses(157.5)(149.5)(153.2)(138.8)(599.0)(161.6)
Income from insurance products (8)63.7 73.7 86.8 135.8 360.0 68.0 
Fee income15.5 0.6 (2.9)17.8 31.0 11.3 
Investment income not allocated to product lines (9)15.5 28.0 38.4 38.3 120.2 12.3 
Expenses not allocated to product lines(18.3)(21.1)7.5 (19.8)(51.7)(16.8)
Operating earnings before taxes76.4 81.2 129.8 172.1 459.5 74.8 
Income tax expense on operating income(17.8)(18.9)(28.5)(38.2)(103.4)(17.3)
Net operating income (10)58.6 62.3 101.3 133.9 356.1 57.5 
Net realized investment gains (losses) from sales, impairments and change in allowance for credit losses(12.7)(31.3)(20.1)1.4 (62.7)(4.6)
Net change in market value of investments recognized in earnings(1.9)(4.0)(9.2)8.8 (6.3)12.4 
Fair value changes related to agent deferred compensation plan— — 6.8 (10.3)(3.5)— 
Changes in fair value of embedded derivative liabilities and market risk benefits(65.1)50.4 109.4 (124.6)(29.9)64.0 
Other2.3 (0.2)(1.1)(1.3)(0.3)(0.4)
Net non-operating income (loss) before taxes(77.4)14.9 85.8 (126.0)(102.7)71.4 
Income tax (expense) benefit on non-operating income (loss)18.0 (3.5)(19.8)28.4 23.1 (16.6)
Net non-operating income (loss)(59.4)11.4 66.0 (97.6)(79.6)54.8 
Net income (loss)$(0.8)$73.7 $167.3 $36.3 $276.5 $112.3 
Per diluted share
Net operating income$0.51 $0.54 $0.88 $1.18 $3.09 $0.52 
Net non-operating income (loss)(0.52)0.10 0.58 (0.86)(0.69)0.49 
Net income (loss)$(0.01)$0.64 $1.46 $0.32 $2.40 $1.01 


Page 5

CNO FINANCIAL GROUP, INC.
Insurance Operations
(Dollars in millions)
(Unaudited)

1Q2Q3Q4QYTD1Q
202320232023202320232024
Insurance product margin (4)
Annuity:
Insurance policy income$5.1 $8.1 $7.2 $8.0 $28.4 $7.3 
Net investment income (5) (6)125.4 127.7 131.0 132.2 516.3 134.5 
Insurance policy benefits(8.7)(10.6)(9.8)0.1 (29.0)(11.3)
Interest credited (6)(48.1)(50.6)(53.4)(57.3)(209.4)(58.3)
Amortization and non-deferred commissions(16.4)(17.5)(18.0)(19.4)(71.3)(20.2)
Annuity margin57.3 57.1 57.0 63.6 235.0 52.0 
Health:
Insurance policy income401.4 397.1 397.8 398.3 1,594.6 398.4 
Net investment income (5)74.0 74.3 74.2 74.2 296.7 74.3 
Insurance policy benefits(318.1)(322.7)(308.5)(285.6)(1,234.9)(308.5)
Amortization and non-deferred commissions(40.8)(40.5)(40.3)(40.5)(162.1)(41.2)
Health margin116.5 108.2 123.2 146.4 494.3 123.0 
Life:
Insurance policy income219.0 223.1 221.0 219.4 882.5 222.7 
Net investment income (5) (7)36.3 36.1 36.3 36.1 144.8 36.5 
Insurance policy benefits(147.2)(142.8)(140.7)(139.3)(570.0)(144.0)
Interest credited (7)(12.1)(12.2)(12.1)(12.9)(49.3)(12.5)
Amortization and non-deferred commissions(19.9)(20.8)(22.1)(23.0)(85.8)(23.5)
Advertising expense(28.7)(25.5)(22.6)(15.7)(92.5)(24.6)
Life margin47.4 57.9 59.8 64.6 229.7 54.6 
Total insurance product margin221.2 223.2 240.0 274.6 959.0 229.6 
Allocated expenses:
Branch office expenses(19.8)(15.9)(16.3)(12.9)(64.9)(19.8)
Other allocated expenses(137.7)(133.6)(136.9)(125.9)(534.1)(141.8)
Income from insurance products (8)63.7 73.7 86.8 135.8 360.0 68.0 
Fee income15.5 0.6 (2.9)17.8 31.0 11.3 
Investment income not allocated to product lines (9)15.5 28.0 38.4 38.3 120.2 12.3 
Expenses not allocated to product lines(18.3)(21.1)7.5 (19.8)(51.7)(16.8)
Operating earnings before taxes76.4 81.2 129.8 172.1 459.5 74.8 
Income tax expense on operating income(17.8)(18.9)(28.5)(38.2)(103.4)(17.3)
Net operating income (10)$58.6 $62.3 $101.3 $133.9 $356.1 $57.5 
Page 6

CNO FINANCIAL GROUP, INC.
Margin from Annuity Products
(Dollars in millions)
(Unaudited)

1Q2Q3Q4QYTD1Q
202320232023202320232024
Annuity margin (4):
Fixed indexed annuities
Insurance policy income$3.6 $5.5 $5.1 $5.5 $19.7 $6.0 
Net investment income (5) (6)98.8 101.2 104.4 105.9 410.3 108.4 
Insurance policy benefits(4.1)(4.2)(4.3)2.5 (10.1)(5.8)
Interest credited (6)(36.4)(38.9)(41.5)(45.1)(161.9)(46.7)
Amortization and non-deferred commissions(15.4)(16.0)(16.5)(17.9)(65.8)(18.5)
Margin from fixed indexed annuities$46.5 $47.6 $47.2 $50.9 $192.2 $43.4 
Average net insurance liabilities (11)$9,183.8 $9,276.0 $9,381.0 $9,508.7 $9,337.3 $9,636.3 
Margin/average net insurance liabilities (12)2.03 %2.05 %2.01 %2.14 %2.06 %1.80 %
Fixed interest annuities
Insurance policy income$0.3 $0.2 $0.3 $0.2 $1.0 $0.1 
Net investment income (5)20.9 20.9 21.0 20.8 83.6 20.6 
Insurance policy benefits(0.1)— (0.1)(0.3)(0.5)(0.4)
Interest credited(11.1)(11.1)(11.4)(11.6)(45.2)(11.1)
Amortization and non-deferred commissions(0.9)(1.3)(1.4)(1.4)(5.0)(1.6)
Margin from fixed interest annuities$9.1 $8.7 $8.4 $7.7 $33.9 $7.6 
Average net insurance liabilities (11)$1,630.9 $1,613.1 $1,603.0 $1,600.9 $1,612.0 $1,588.0 
Margin/average net insurance liabilities (12)2.23 %2.16 %2.10 %1.92 %2.10 %1.91 %
Other annuities
Insurance policy income$1.2 $2.4 $1.8 $2.3 $7.7 $1.2 
Net investment income (5)5.7 5.6 5.6 5.5 22.4 5.5 
Insurance policy benefits(4.5)(6.4)(5.4)(2.1)(18.4)(5.1)
Interest credited(0.6)(0.6)(0.5)(0.6)(2.3)(0.5)
Amortization and non-deferred commissions(0.1)(0.2)(0.1)(0.1)(0.5)(0.1)
Margin from other annuities$1.7 $0.8 $1.4 $5.0 $8.9 $1.0 
Average net insurance liabilities (11)$469.5 $462.5 $455.6 $447.5 $458.8 $439.9 
Margin/average net insurance liabilities (12)1.45 %0.69 %1.23 %4.47 %1.94 %0.91 %
Total annuity margin$57.3 $57.1 $57.0 $63.6 $235.0 $52.0 
Average net insurance liabilities (11)$11,284.2 $11,351.6 $11,439.6 $11,557.1 $11,408.1 $11,664.2 
Margin/average net insurance liabilities (12)2.03 %2.01 %1.99 %2.20 %2.06 %1.78 %
Page 7

CNO FINANCIAL GROUP, INC.
Margin from Health Products
(Dollars in millions)
(Unaudited)

1Q2Q3Q4QYTD1Q
202320232023202320232024
Health margin (4):
Supplemental health
Insurance policy income$179.0 $176.2 $177.9 $178.1 $711.2 $179.7 
Net investment income (5)38.6 38.9 39.0 38.8 155.3 39.0 
Insurance policy benefits(128.2)(128.9)(128.0)(81.0)(466.1)(125.8)
Amortization and non-deferred commissions(26.1)(26.3)(26.1)(27.5)(106.0)(27.5)
Margin from supplemental health$63.3 $59.9 $62.8 $108.4 $294.4 $65.4 
Margin/insurance policy income35 %34 %35 %61 %41 %36 %
Medicare supplement
Insurance policy income$156.5 $155.3 $154.2 $153.9 $619.9 $151.7 
Net investment income (5)1.3 1.2 1.1 1.3 4.9 1.4 
Insurance policy benefits(120.5)(113.4)(107.4)(123.4)(464.7)(116.4)
Amortization and non-deferred commissions(11.2)(10.8)(10.7)(10.5)(43.2)(10.2)
Margin from Medicare supplement$26.1 $32.3 $37.2 $21.3 $116.9 $26.5 
Margin/insurance policy income17 %21 %24 %14 %19 %17 %
Long-term care
Insurance policy income$65.9 $65.6 $65.7 $66.3 $263.5 $67.0 
Net investment income (5)34.1 34.2 34.1 34.1 136.5 33.9 
Insurance policy benefits(69.4)(80.4)(73.1)(81.2)(304.1)(66.3)
Amortization and non-deferred commissions(3.5)(3.4)(3.5)(2.5)(12.9)(3.5)
Margin from long-term care$27.1 $16.0 $23.2 $16.7 $83.0 $31.1 
Margin/insurance policy income41 %24 %35 %25 %31 %46 %
Total health margin$116.5 $108.2 $123.2 $146.4 $494.3 $123.0 
Margin/insurance policy income29 %27 %31 %37 %31 %31 %
Page 8

CNO FINANCIAL GROUP, INC.
Margin from Life Products
(Dollars in millions)
(Unaudited)

1Q2Q3Q4QYTD1Q
202320232023202320232024
Life margin (4):
Interest sensitive life
Insurance policy income$44.5 $45.3 $45.1 $46.2 $181.1 $46.6 
Net investment income (5) (7)13.1 12.7 12.9 12.8 51.5 13.2 
Insurance policy benefits(18.2)(17.1)(18.1)(12.3)(65.7)(19.9)
Interest credited (7)(12.0)(12.0)(11.9)(12.8)(48.7)(12.3)
Amortization and non-deferred commissions(4.6)(4.8)(5.1)(5.0)(19.5)(5.1)
Margin from interest sensitive life$22.8 $24.1 $22.9 $28.9 $98.7 $22.5 
Average net insurance liabilities (11)$1,032.0 $1,035.4 $1,039.6 $1,045.8 $1,038.2 $1,056.1 
Interest margin$1.1 $0.7 $1.0 $— $2.8 $0.9 
Interest margin/average net insurance liabilities (12)0.43 %0.27 %0.38 %— %0.27 %0.34 %
Underwriting margin$21.7 $23.4 $21.9 $28.9 $95.9 $21.6 
Underwriting margin/insurance policy income49 %52 %49 %63 %53 %46 %
Traditional life
Insurance policy income$174.5 $177.8 $175.9 $173.2 $701.4 $176.1 
Net investment income (5)23.2 23.4 23.4 23.3 93.3 23.3 
Insurance policy benefits(129.0)(125.7)(122.6)(127.0)(504.3)(124.1)
Interest credited(0.1)(0.2)(0.2)(0.1)(0.6)(0.2)
Amortization and non-deferred commissions(15.3)(16.0)(17.0)(18.0)(66.3)(18.4)
Advertising expense(28.7)(25.5)(22.6)(15.7)(92.5)(24.6)
Margin from traditional life$24.6 $33.8 $36.9 $35.7 $131.0 $32.1 
Margin/insurance policy income14 %19 %21 %21 %19 %18 %
Margin excluding advertising expense/insurance policy income31 %33 %34 %30 %32 %32 %
Total life margin$47.4 $57.9 $59.8 $64.6 $229.7 $54.6 



Page 9

CNO FINANCIAL GROUP, INC.
Collected Premiums and Insurance Policy Income
(Dollars in millions)
(Unaudited)

1Q2Q3Q4QYTD1Q
202320232023202320232024
Collected premiums:
Annuity products
Fixed indexed annuities$323.3 $351.6 $321.8 $377.2 $1,373.9 $345.5 
Fixed interest annuities46.1 46.6 48.9 58.1 199.7 45.9 
Other annuities1.5 3.6 1.5 3.0 9.6 1.9 
Total annuity collected premiums370.9 401.8 372.2 438.3 1,583.2 393.3 
Health products
Supplemental health180.0 175.8 175.6 175.2 706.6 181.4 
Medicare supplement158.4 148.4 146.6 156.0 609.4 155.7 
Long-term care66.5 65.1 63.9 66.3 261.8 67.7 
Total health collected premiums404.9 389.3 386.1 397.5 1,577.8 404.8 
Life products
Interest-sensitive life58.2 60.3 58.3 60.2 237.0 60.5 
Traditional life176.4 176.3 175.2 172.1 700.0 176.8 
Total life collected premiums234.6 236.6 233.5 232.3 937.0 237.3 
Total collected premiums$1,010.4 $1,027.7 $991.8 $1,068.1 $4,098.0 $1,035.4 
Insurance policy income:
Annuity products
Fixed indexed annuities$3.6 $5.5 $5.1 $5.5 $19.7 $6.0 
Fixed interest annuities0.3 0.2 0.3 0.2 1.0 0.1 
Other annuities1.2 2.4 1.8 2.3 7.7 1.2 
Total annuity insurance policy income5.1 8.1 7.2 8.0 28.4 7.3 
Health products
Supplemental health179.0 176.2 178.0 178.1 711.3 179.7 
Medicare supplement156.5 155.3 154.1 153.9 619.8 151.7 
Long-term care65.9 65.6 65.7 66.3 263.5 67.0 
Total health insurance policy income401.4 397.1 397.8 398.3 1,594.6 398.4 
Life products
Interest-sensitive life 44.5 45.3 45.1 46.2 181.1 46.6 
Traditional life 174.5 177.8 175.9 173.2 701.4 176.1 
Total life insurance policy income219.0 223.1 221.0 219.4 882.5 222.7 
Total insurance policy income$625.5 $628.3 $626.0 $625.7 $2,505.5 $628.4 


Page 10

CNO FINANCIAL GROUP, INC.
Health and Life
New Annualized Premiums ("NAP")
(Dollars in millions)
(Unaudited)

1Q2Q3Q4QYTD1Q
202320232023202320232024
Consumer Division
Health products:
Supplemental health$17.4 $18.7 $19.2 $19.2 $74.5 $18.0 
Medicare supplement7.8 8.9 8.7 11.5 36.9 9.7 
Long-term care6.2 5.7 8.9 11.1 31.9 10.6 
Total Consumer Division health NAP31.4 33.3 36.8 41.8 143.3 38.3 
Life products:
Interest sensitive life4.6 6.3 4.4 4.5 19.8 4.4 
Traditional life49.7 46.0 41.9 35.5 173.1 48.8 
Total Consumer Division life NAP54.3 52.3 46.3 40.0 192.9 53.2 
Total Consumer Division health and life NAP$85.7 $85.6 $83.1 $81.8 $336.2 $91.5 
Worksite Division
Health products:
Supplemental health$8.1 $9.8 $11.5 $10.4 $39.8 $9.5 
Life products:
Interest sensitive life2.8 3.3 3.7 3.9 13.7 3.5 
Total Worksite Division health and life NAP$10.9 $13.1 $15.2 $14.3 $53.5 $13.0 
Total NAP (both divisions)
Health products:
Supplemental health$25.5 $28.5 $30.7 $29.6 $114.3 $27.5 
Medicare supplement7.8 8.9 8.7 11.5 36.9 9.7 
Long-term care6.2 5.7 8.9 11.1 31.9 10.6 
Total health NAP39.5 43.1 48.3 52.2 183.1 47.8 
Life products:
Interest sensitive life 7.4 9.6 8.1 8.4 33.5 7.9 
Traditional life 49.7 46.0 41.9 35.5 173.1 48.8 
Total life NAP57.1 55.6 50.0 43.9 206.6 56.7 
Total NAP$96.6 $98.7 $98.3 $96.1 $389.7 $104.5 

Page 11

CNO FINANCIAL GROUP, INC.
Computation of Weighted Average Shares Outstanding
(Shares in thousands)

1Q2Q3Q4QYTD1Q
2023 (a)20232023202320232024
Basic
Shares outstanding, beginning of period114,343.1 114,905.2 113,673.9 112,163.2 114,343.1 109,357.5 
Weighted average share activity during the period:
Shares repurchased(255.7)(675.8)(1,006.4)(630.0)(2,201.3)(618.6)
Amounts related to employee benefit plans671.8 45.9 23.5 61.2 1,571.6 344.5 
Shares withheld for the payment of the exercise price and taxes related to employee benefit plans(214.3)(1.8)(1.9)(3.8)(438.9)(119.5)
Weighted average basic shares outstanding during the period114,544.9 114,273.5 112,689.1 111,590.6 113,274.5 108,963.9 
Basic shares outstanding, end of period114,905.2 113,673.9 112,163.2 109,357.5 109,357.5 108,568.6 
Diluted
Weighted average basic shares outstanding114,544.9 114,273.5 112,689.1 111,590.6 113,274.5 108,963.9 
Common stock equivalent shares related to:
Employee benefit plans— 1,376.1 1,772.8 2,066.6 1,849.5 1,881.0 
Weighted average diluted shares outstanding during the period114,544.9 115,649.6 114,461.9 113,657.2 115,124.0 110,844.9 
Diluted shares outstanding, end of period116,176.0 115,303.3 113,974.7 111,750.3 111,750.3 110,036.5 

___________
(a)    Equivalent common shares of 2,182.5 were not included in the weighted average shares outstanding due to the net loss recognized in 1Q23.



Page 12

CNO FINANCIAL GROUP, INC.
Annuities - Account Value Rollforwards
(Dollars in millions)

1Q2Q3Q4QYTD1Q
202320232023202320232024
Fixed indexed annuities
Balance, beginning of period excluding contracts 100% ceded$9,490.4 $9,584.3 $9,707.7 $9,819.2 $9,490.4 $9,999.2 
Issuances (funds collected from new business)323.3 351.6 321.7 377.1 1,373.7 345.4 
Premiums received (premiums collected from inforce business)0.4 (0.2)0.1 (0.2)0.1 0.5 
Policy charges(4.0)(5.2)(5.2)(5.3)(19.7)(6.5)
Surrenders and withdrawals(178.2)(182.6)(177.6)(199.9)(738.3)(232.2)
Benefit payments(59.2)(63.1)(62.7)(58.9)(243.9)(74.4)
Interest credited6.1 17.2 29.4 59.9 112.6 68.9 
Other5.5 5.7 5.8 7.3 24.3 11.8 
Balance, end of period excluding contracts 100% ceded$9,584.3 $9,707.7 $9,819.2 $9,999.2 $9,999.2 $10,112.7 
Fixed interest annuities
Balance, beginning of period excluding contracts 100% ceded$1,663.1 $1,649.3 $1,636.6 $1,632.5 $1,663.1 $1,636.4 
Issuances (funds collected from new business)45.3 45.8 48.4 57.5 197.0 45.1 
Premiums received (premiums collected from inforce business)0.7 0.9 0.5 0.6 2.7 1.0 
Policy charges(0.2)(0.2)(0.3)(0.3)(1.0)(0.3)
Surrenders and withdrawals(43.3)(42.1)(39.3)(39.9)(164.6)(52.8)
Benefit payments(27.7)(28.2)(24.9)(26.1)(106.9)(30.2)
Interest credited11.3 11.2 11.7 11.9 46.1 11.4 
Other0.1 (0.1)(0.2)0.2 — — 
Balance, end of period excluding contracts 100% ceded$1,649.3 $1,636.6 $1,632.5 $1,636.4 $1,636.4 $1,610.6 
Total annuities
Balance, beginning of period excluding contracts 100% ceded$11,153.5 $11,233.6 $11,344.3 $11,451.7 $11,153.5 $11,635.6 
Issuances (funds collected from new business)368.6 397.4 370.1 434.6 1,570.7 390.5 
Premiums received (premiums collected from inforce business)1.1 0.7 0.6 0.4 2.8 1.5 
Policy charges(4.2)(5.4)(5.5)(5.6)(20.7)(6.8)
Surrenders and withdrawals(221.5)(224.7)(216.9)(239.8)(902.9)(285.0)
Benefit payments(86.9)(91.3)(87.6)(85.0)(350.8)(104.6)
Interest credited17.4 28.4 41.1 71.8 158.7 80.3 
Other5.6 5.6 5.6 7.5 24.3 11.8 
Balance, end of period excluding contracts 100% ceded$11,233.6 $11,344.3 $11,451.7 $11,635.6 $11,635.6 $11,723.3 
Page 13

CNO FINANCIAL GROUP, INC.
Consolidated Statutory Information of U.S. Based Insurance Subsidiaries (13)
(Dollars in millions)
(Unaudited)

1Q2Q3Q4QYTD1Q
202320232023202320232024 (a)
Net gain from operations before interest expense and federal income taxes$58.3 $55.6 $54.0 $67.4 $235.3 $40.3 
Interest expense on surplus debentures held by parent company15.9 16.6 31.6 17.9 82.0 17.6 
Net gain from operations before federal income taxes42.4 39.0 22.4 49.5 153.3 22.7 
Federal income tax expense (benefit)3.3 1.9 (15.0)31.8 22.0 26.7 
Net gain (loss) from operations before net realized capital gains (losses)39.1 37.1 37.4 17.7 131.3 (4.0)
Net realized capital gains (losses)(1.3)(20.6)(6.2)1.8 (26.3)(4.2)
Net income (loss)$37.8 $16.5 $31.2 $19.5 $105.0 $(8.2)
Capital and surplus$1,831.3 $1,857.0 $1,932.6 $1,558.9 $1,558.9 $1,487.3 
Asset valuation reserve (AVR)317.8 316.5 333.9 352.5 352.5 351.8 
Capital, surplus and AVR2,149.1 2,173.5 2,266.5 1,911.4 1,911.4 1,839.1 
Interest maintenance reserve (IMR)385.6 381.7 372.1 368.1 368.1 362.1 
Total statutory capital, surplus, AVR & IMR$2,534.7 $2,555.2 $2,638.6 $2,279.5 $2,279.5 $2,201.2 
Risk-based capital ratio380 %386 %392 %402 %402 %391 %


___________
(a)    Such amounts are preliminary as the statutory basis financial statements of our U.S. based insurance subsidiaries for 1Q24 will be filed with the respective insurance regulators on or about May 15, 2024.
Page 14

CNO FINANCIAL GROUP, INC.
Investment Income Not Allocated to Product Lines (9)
(Dollars in millions)
(Unaudited)

1Q2Q3Q4QYTD1Q
202320232023202320232024
Net investment income$343.0 $399.7 $291.8 $465.2 $1,499.7 $469.2 
Allocated to product lines:
Annuity(125.4)(127.7)(131.0)(132.2)(516.3)(134.5)
Health(74.0)(74.3)(74.2)(74.2)(296.7)(74.3)
Life(36.3)(36.1)(36.3)(36.1)(144.8)(36.5)
Equity returns credited to policyholder account balances(18.6)(62.3)54.6 (105.2)(131.5)(139.7)
Amounts allocated to product lines and credited to policyholder account balances(254.3)(300.4)(186.9)(347.7)(1,089.3)(385.0)
Impact of annual option forfeitures related to fixed indexed annuity surrenders— 1.4 2.5 3.2 7.1 6.2 
Amount related to variable interest entities and other non-operating items(20.9)(19.0)(18.7)(16.2)(74.8)(12.6)
Interest expense on debt(15.7)(15.6)(15.7)(15.7)(62.7)(15.7)
Interest expense on financing arrangements— — (1.1)(1.3)(2.4)(1.2)
Interest expense on investment borrowings from the Federal Home Loan Bank ("FHLB") program(21.7)(24.2)(28.3)(30.5)(104.7)(31.4)
Expenses related to the funding agreement-backed notes ("FABN") program (a)(7.6)(7.6)(7.6)(7.6)(30.4)(7.6)
Less amounts credited to deferred compensation plans (offsetting investment income)(7.3)(6.3)2.4 (11.1)(22.3)(9.6)
Total adjustments(73.2)(71.3)(66.5)(79.2)(290.2)(71.9)
Investment income not allocated to product lines$15.5 $28.0 $38.4 $38.3 $120.2 $12.3 

___________
(a)    Comprised of interest credited and amortization of deferred acquisition costs.


Page 15

CNO FINANCIAL GROUP, INC.
Investment Income Not Allocated to Product Lines (9)
(Dollars in millions)
(Unaudited)
1Q2Q3Q4QYTD1Q
202320232023202320232024
Investment income not allocated:
Excluding variable components:
From general account assets$24.9 $26.4 $27.2 $29.8 $108.3 $27.1 
Other investment income1.9 2.0 2.4 3.0 9.3 3.1 
Spread income:
FHLB program:
Investment income on matched assets31.8 34.7 39.4 41.5 147.4 41.7 
Interest expense(21.7)(24.2)(28.3)(30.5)(104.7)(31.4)
Net spread income on FHLB program10.1 10.5 11.1 11.0 42.7 10.3 
FABN program:
Investment income on matched assets13.8 14.6 15.8 14.8 59.0 14.9 
Expenses (b)(7.6)(7.6)(7.6)(7.6)(30.4)(7.6)
Net spread income on FABN program6.2 7.0 8.2 7.2 28.6 7.3 
Interest expense on corporate debt(15.7)(15.6)(15.7)(15.7)(62.7)(15.7)
Interest expense on financing arrangements— — (1.1)(1.3)(2.4)(1.2)
Total excluding variable components 27.4 30.3 32.1 34.0 123.8 30.9 
Variable components:
Net income from Corporate Owned Life Insurance ("COLI") supporting agent deferred compensation plan:
Change in value of COLI investments2.2 2.4 2.6 5.8 13.0 3.6 
Increase in liability for agent deferred compensation plan(1.6)(1.6)(1.7)(1.6)(6.5)(1.6)
Net COLI income (loss)0.6 0.8 0.9 4.2 6.5 2.0 
Other variable components:
Alternative investment income (loss):
Total(9.4)0.2 6.5 0.9 (1.8)(24.3)
Allocated to product lines(7.8)(7.8)(7.5)(7.4)(30.5)(7.1)
Excess alternative investment income (loss)(17.2)(7.6)(1.0)(6.5)(32.3)(31.4)
Prepayment and call income0.1 0.1 0.1 0.2 0.5 — 
Trading account2.6 1.3 1.3 1.3 6.5 2.1 
Hedge variance related to fixed indexed products— (1.0)(0.3)(1.2)(2.5)0.5 
Impact of annual option forfeitures related to fixed indexed annuity surrenders— 1.4 2.5 3.2 7.1 6.2 
Other (a)2.0 2.7 2.8 3.1 10.6 2.0 
Total variable components(11.9)(2.3)6.3 4.3 (3.6)(18.6)
Total investment income not allocated to product lines $15.5 $28.0 $38.4 $38.3 $120.2 $12.3 
___________
(a)    Includes impacts of changes in projected cash flows and other investment income.
(b)    Comprised of interest credited and amortization of deferred acquisition costs.
Page 16

CNO FINANCIAL GROUP, INC.
Investment Income Allocated to Product Lines (5)
(Dollars in millions)
(Unaudited)
1Q2Q3Q4QYTD1Q
202320232023202320232024
Average net insurance liabilities (11)
Annuity:
Fixed indexed annuities$9,183.8 $9,276.0 $9,381.0 $9,508.7 $9,337.3 $9,636.3 
Fixed interest annuities1,630.9 1,613.1 1,603.0 1,600.9 1,612.0 1,588.0 
Other annuities469.5 462.5 455.6 447.5 458.8 439.9 
Total annuity average net insurance liabilities (11)11,284.2 11,351.6 11,439.6 11,557.1 11,408.1 11,664.2 
Health:
Supplemental health3,331.0 3,350.6 3,365.8 3,356.9 3,351.1 3,346.3 
Medicare supplement124.2 118.7 107.1 106.7 114.2 114.8 
Long-term care2,659.8 2,670.5 2,681.9 2,692.5 2,676.1 2,698.7 
Total health average net insurance liabilities (11)6,115.0 6,139.8 6,154.8 6,156.1 6,141.4 6,159.8 
Life:
Interest sensitive1,032.0 1,035.4 1,039.6 1,045.8 1,038.2 1,056.1 
Traditional1,973.0 1,975.3 1,981.8 1,989.0 1,979.8 1,994.1 
Total life average net insurance liabilities (11)3,005.0 3,010.7 3,021.4 3,034.8 3,018.0 3,050.2 
Total average net insurance liabilities (11)$20,404.2 $20,502.1 $20,615.8 $20,748.0 $20,567.5 $20,874.2 
Average yield on allocated investments
Annuity:
Fixed indexed annuities4.30 %4.36 %4.45 %4.45 %4.39 %4.50 %
Fixed interest annuities5.13 %5.18 %5.24 %5.20 %5.19 %5.19 %
Other annuities4.86 %4.84 %4.92 %4.92 %4.88 %5.00 %
Average yield on investments allocated to annuities4.45 %4.50 %4.58 %4.58 %4.53 %4.61 %
Health:
Supplemental health4.64 %4.64 %4.63 %4.62 %4.63 %4.66 %
Medicare supplement4.13 %4.19 %4.25 %4.42 %4.24 %4.73 %
Long-term care5.13 %5.12 %5.09 %5.07 %5.10 %5.02 %
Average yield on investments allocated to health products4.84 %4.84 %4.82 %4.82 %4.83 %4.82 %
Life:
Interest sensitive5.08 %4.91 %4.96 %4.90 %4.96 %5.00 %
Traditional4.70 %4.74 %4.72 %4.69 %4.71 %4.67 %
Average yield on investments allocated to life products4.83 %4.80 %4.81 %4.76 %4.80 %4.79 %
Total average yield4.62 %4.65 %4.69 %4.68 %4.66 %4.70 %
Allocated investment income
Annuity:
Fixed indexed annuities$98.8 $101.2 $104.4 $105.9 $410.3 $108.4 
Fixed interest annuities20.9 20.9 21.0 20.8 83.6 20.6 
Other annuities5.7 5.6 5.6 5.5 22.4 5.5 
Total investment income allocated to annuities125.4 127.7 131.0 132.2 516.3 134.5 
Health:
Supplemental health38.6 38.9 39.0 38.8 155.3 39.0 
Medicare supplement1.3 1.2 1.1 1.3 4.9 1.4 
Long-term care34.1 34.2 34.1 34.1 136.5 33.9 
Total investment income allocated to health products74.0 74.3 74.2 74.2 296.7 74.3 
Life:
   Interest sensitive13.1 12.7 12.9 12.8 51.5 13.2 
Traditional23.2 23.4 23.4 23.3 93.3 23.3 
Total investment income allocated to life products36.3 36.1 36.3 36.1 144.8 36.5 
Total allocated investment income$235.7 $238.1 $241.5 $242.5 $957.8 $245.3 
Page 17

CNO FINANCIAL GROUP, INC.
Investment Income Not Allocated to Product Lines (9)
(Dollars in millions)
(Unaudited)

1Q2Q3Q4QYTD1Q
202320232023202320232024
General account assets investment income$292.2 $308.1 $324.8 $325.1 $1,250.2 $301.9 
Policyholder and other special purpose portfolio investment income (loss)50.8 91.6 (33.0)140.1 249.5 167.3 
Less equity returns credited to policyholders:
Annuity(16.5)(56.1)49.8 (95.5)(118.3)(128.6)
Life(2.1)(6.2)4.8 (9.7)(13.2)(11.1)
Less amount related to variable interest entities(20.9)(19.0)(18.7)(16.2)(74.8)(12.6)
Less amounts credited to deferred compensation plans(7.3)(6.3)2.4 (11.1)(22.3)(9.6)
Other special purpose portfolio investment income (loss)4.0 4.0 5.3 7.6 20.9 5.4 
Adjusted net investment income296.2 312.1 330.1 332.7 1,271.1 307.3 
Less amounts allocated to product lines
Annuity(125.4)(127.7)(131.0)(132.2)(516.3)(134.5)
Health(74.0)(74.3)(74.2)(74.2)(296.7)(74.3)
Life(36.3)(36.1)(36.3)(36.1)(144.8)(36.5)
Total investment income allocated to product lines(235.7)(238.1)(241.5)(242.5)(957.8)(245.3)
Impact of annual option forfeitures related to fixed indexed annuity surrenders— 1.4 2.5 3.2 7.1 6.2 
Less interest expense on investment borrowings from FHLB program(21.7)(24.2)(28.3)(30.5)(104.7)(31.4)
Less expenses related to FABN program(7.6)(7.6)(7.6)(7.6)(30.4)(7.6)
Less interest expense on debt(15.7)(15.6)(15.7)(15.7)(62.7)(15.7)
Less interest expense on financing arrangements— — (1.1)(1.3)(2.4)(1.2)
Investment income not allocated to product lines$15.5 $28.0 $38.4 $38.3 $120.2 $12.3 

Other Investment Data

1Q2Q3Q4Q1Q
20232023202320232024
Average book value of invested assets and cash$26,801.8 $26,900.3 $27,287.6 $27,648.7 $27,897.0 
Net investment income from general account investments292.2 308.1 324.8 325.1 301.9 
New money rate (14)6.34 %6.32 %6.03 %6.92 %6.17 %
Book yield (15)4.56 %4.58 %4.60 %4.62 %4.64 %
Earned yield (16)4.22 %4.41 %4.55 %4.49 %4.06 %
Pre-pay/call/make-whole income$0.1 $0.1 $0.1 $0.2 $— 
Alternative investment income (loss)(9.4)0.2 6.5 0.9 (24.3)

Page 18

CNO FINANCIAL GROUP, INC.
4Q23 Significant Items
(Dollars in millions, except per share amounts)
(Unaudited)

The table below summarizes the financial impact of significant items on our 4Q23 net operating income. Management believes that identifying the impact of these items enhances the understanding of our operating results.
Three months ended
December 31, 2023
Actual resultsSignificant itemsExcluding significant
items
Insurance product margin (4)
Annuity margin$63.6 $(12.9)(a)$50.7 
Health margin146.4 (22.3)(a)124.1 
Life margin64.6 1.3 (a)65.9 
Total insurance product margin274.6 (33.9)240.7 
Allocated expenses(138.8)— (138.8)
Income from insurance products (5)135.8 (33.9)101.9 
Fee income17.8 — 17.8 
Investment income not allocated to product lines (9)38.3 — 38.3 
Expenses not allocated to product lines(19.8)— (19.8)
Operating earnings before taxes172.1 (33.9)138.2 
Income tax (expense) benefit on operating income(38.2)7.5 (30.7)
Net operating income (10)$133.9 $(26.4)$107.5 
Net operating income per diluted share$1.18 $(0.23)$0.95 
___________
(a)Comprised of $33.9 million of the net favorable impact arising from our comprehensive annual actuarial assumption and model review.

CNO FINANCIAL GROUP, INC.
3Q23 Significant Items
(Dollars in millions, except per share amounts)
(Unaudited)

The table below summarizes the financial impact of significant items on our 3Q23 net operating income. Management believes that identifying the impact of these items enhances the understanding of our operating results.
Three months ended
September 30, 2023
Actual resultsSignificant itemsExcluding significant
items
Insurance product margin (4)
Annuity margin$57.0 $— $57.0 
Health margin123.2 — 123.2 
Life margin59.8 — 59.8 
Total insurance product margin240.0 — 240.0 
Allocated expenses(153.2)— (153.2)
Income from insurance products (5)86.8 — 86.8 
Fee income(2.9)— (2.9)
Investment income not allocated to product lines (9)38.4 — 38.4 
Expenses not allocated to product lines7.5 (21.7)(a)(14.2)
Operating earnings before taxes129.8 (21.7)108.1 
Income tax (expense) benefit on operating income(28.5)4.8 (23.7)
Net operating income (10)$101.3 $(16.9)$84.4 
Net operating income per diluted share$0.88 $(0.14)$0.74 
___________
(a)Comprised of $21.7 million of legal recoveries, net of expenses and increased legal accruals.


Page 19

CNO FINANCIAL GROUP, INC.
4Q22 Significant Items
(Dollars in millions, except per share amounts)
(Unaudited)

The table below summarizes the financial impact of significant items on our 4Q22 net operating income. Management believes that identifying the impact of these items enhances the understanding of our operating results.
Three months ended
December 31, 2022
Actual resultsSignificant itemsExcluding significant
items
Insurance product margin (4)
Annuity margin$50.8 $3.2 (a)$54.0 
Health margin140.4 (18.3)(a)122.1 
Life margin43.3 14.4 (a)57.7 
Total insurance product margin234.5 (0.7)233.8 
Allocated expenses(149.1)— (149.1)
Income from insurance products (5)85.4 (0.7)84.7 
Fee income9.2 — 9.2 
Investment income not allocated to product lines (9)25.2 — 25.2 
Expenses not allocated to product lines(12.8)— (12.8)
Operating earnings before taxes107.0 (0.7)106.3 
Income tax (expense) benefit on operating income(24.1)0.2 (23.9)
Net operating income (10)$82.9 $(0.5)$82.4 
Net operating income per diluted share$0.71 $— $0.71 
___________
(a)Comprised of $.7 million of the net favorable impact arising from our comprehensive annual actuarial assumption and model review.

CNO FINANCIAL GROUP, INC.
2Q22 Significant Items
(Dollars in millions, except per share amounts)
(Unaudited)

The table below summarizes the financial impact of significant items on our 2Q22 net operating income. Management believes that identifying the impact of these items enhances the understanding of our operating results.

Three months ended
June 30, 2022
Actual resultsSignificant itemsExcluding significant
items
Insurance product margin (4)
Annuity margin$60.1 $— $60.1 
Health margin125.4 — 125.4 
Life margin70.2 — 70.2 
Total insurance product margin255.7 — 255.7 
Allocated expenses(152.2)— (152.2)
Income from insurance products (5)103.5 — 103.5 
Fee income3.2 — 3.2 
Investment income not allocated to product lines (9)64.6 — 64.6 
Expenses not allocated to product lines2.9 (22.5)(a)(19.6)
Operating earnings before taxes174.2 (22.5)151.7 
Income tax (expense) benefit on operating income(39.1)5.1 (34.0)
Net operating income (10)$135.1 $(17.4)$117.7 
Net operating income per diluted share$1.15 $(0.15)$1.00 
___________
(a)Comprised of an experience refund of $22.5 million related to a reinsurance agreement.
Page 20

Notes

(1)Excludes accumulated other comprehensive income (loss). Management believes this non-GAAP measure is useful because it removes the volatility that arises from changes in the unrealized appreciation (depreciation) of our investments.
(2)Shareholders' equity divided by common shares outstanding.
(3)Book value per diluted share reflects the potential dilution that could occur if outstanding stock options were exercised and restricted stock and performance units were vested. The dilution from options, restricted shares and performance units is calculated using the treasury stock method. Under this method, we assume the proceeds from the exercise of the options (or the unrecognized compensation expense with respect to restricted stock and performance units) will be used to purchase shares of our common stock at the closing market price on the last day of the period.
(4)Insurance margin is management’s measure of profitability of its annuity, health and life product lines’ performance and consists of insurance policy income plus allocated investment income less insurance policy benefits, interest credited, commissions, advertising expense and amortization of acquisition costs. Income from insurance products is the sum of the insurance margins of the annuity, health and life product lines, less expenses allocated to the insurance product lines. It excludes the income from our fee income business, investment income not allocated to product lines, net expenses not allocated to product lines (primarily holding company expenses) and income taxes. Management believes this information helps provide a better understanding of the business and a more meaningful analysis of results of our insurance product lines. Income from insurance products, a non-GAAP measure, is a component of net operating income, which is reconciled to net income on page 5 of this Quarterly Financial Supplement.
(5)Investment income is allocated to the product lines using the book yield of investments backing the block of business, which is applied to the average net insurance liabilities for the block in each period. See note (11) for definition of net insurance liabilities.
(6)Excludes the change in market values of the underlying options supporting the fixed indexed annuity products and corresponding amount credited to policyholder account balances. Such amounts were $16.5 million, $56.1 million, $(49.8) million, $95.5 million and $128.6 million in 1Q23, 2Q23, 3Q23, 4Q23 and 1Q24, respectively.
(7)Excludes the change in market values of the underlying options supporting the fixed indexed life products and corresponding amount credited to policyholder account balances. Such amounts were $2.1 million, $6.2 million, $(4.8) million, $9.7 million and $11.1 million in 1Q23, 2Q23, 3Q23, 4Q23 and 1Q24, respectively.
(8)Income from insurance products is the sum of the insurance margins of the annuity, health and life product lines, less expenses allocated to the insurance lines. It excludes the income from our fee income business, investment income not allocated to product lines, net expenses not allocated to product lines (primarily holding company expenses) and income taxes. Management believes this information helps provide a better understanding of the business and a more meaningful analysis of results of our insurance product lines. Income from insurance products, a non-GAAP measure, is a component of net operating income, which is reconciled to net income on page 5 of this Quarterly Financial Supplement.
(9)Investment income not allocated to product lines represents net investment income less: (i) equity returns credited to policyholder account balances; (ii) the investment income allocated to our product lines; (iii) interest expense on notes payable, investment borrowings and financing arrangements; (iv) expenses related to the FABN program; and (v) certain expenses related to benefit plans that are offset by special-purpose investment income; plus (vi) the impact of annual option forfeitures related to fixed indexed annuity surrenders. Investment income not allocated to product lines includes investment income on investments in excess of of amounts allocated to product lines, investments held by our holding companies, the spread we earn from our Federal Home Loan Bank investment borrowing and FABN programs and variable components of investment income (including call and prepayment income, adjustments to returns on structured securities due to cash flow changes, income (loss) from company-owned life insurance ("COLI") and alternative investments income not allocated to product lines), net of interest expense on corporate debt and financing arrangements.
(10)Management believes that an analysis of Net income applicable to common stock before: (i) net realized investment gains or losses from sales, impairments and change in allowance for credit losses, net of taxes; (ii) net change in market value of investments recognized in earnings, net of taxes; (iii) changes in fair value of embedded derivative liabilities and market risk benefits related to our fixed indexed annuities, net of taxes; (iv) fair value changes related to the agent deferred compensation plan, net of taxes; (v) loss related to reinsurance transaction, net of taxes; (vi) loss on extinguishment of debt, net of taxes; (vii) changes in the valuation allowance for deferred tax assets and other tax items; and (viii) other non-operating items consisting primarily of earnings attributable to variable interest entities, net of taxes (“Net operating income,” a non-GAAP financial measure) is important to evaluate the financial performance of the company, and is a key measure commonly used in the life insurance industry. Management uses this measure to evaluate performance because the items excluded from net operating income can be affected by events that are unrelated to the company's underlying fundamentals.
(11)Net insurance liabilities for the purpose of allocating investment income to product lines are equal to: (i) policyholder account balances for annuity products; (ii) total reserves before the fair value adjustments reflected in accumulated other comprehensive income (loss), if applicable, for all other products; less (iii) amounts related to reinsurance business; (iv) deferred acquisition costs; (v) the present value of future profits; and (vi) the value of unexpired options credited to insurance liabilities.
(12)Margin/average net insurance liabilities for quarterly periods is calculated by annualizing the quarters' margin divided by the average net insurance liabilities.
(13)Based on statutory accounting practices prescribed or permitted by regulatory authorities for CNO Financial's U.S. based insurance subsidiaries after appropriate elimination of intercompany accounts among such subsidiaries. Such accounting practices differ from GAAP.
(14)The new money rate is for the investments purchased during the period to support our insurance products and capital. It excludes the new money rate on investments purchased with investment borrowings under our Federal Home Loan Bank and FABN programs and investments purchased by the variable interest entities.

Page 21

Notes (continued)
(15)Book yield on fixed maturity investments, excluding investments held in the: (i) Federal Home Loan Bank and FABN programs; and (ii) the investments held by the variable interest entities.
(16)Earned yield is the investment income earned during the period divided by the average book value of the investment portfolio, excluding: (i) investments held in the Federal Home Loan Bank and FABN programs; and (ii) the investments held by the variable interest entities.
Page 22
1 Unless otherwise specified, comparisons in this presentation are between 1Q23 and 1Q24. First Quarter 2024 Financial and operating results for the period ended March 31, 2024 April 29, 2024 Exhibit 99.3

 
2 Certain statements made in this presentation should be considered forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. These include statements about future results of operations and capital plans. We caution investors that these forward-looking statements are not guarantees of future performance, and actual results may differ materially. Investors should consider the important risks and uncertainties that may cause actual results to differ, including those included in our press release issued on April 29, 2024, our Quarterly Reports on Form 10-Q, our Annual Report on Form 10-K and other filings we make with the Securities and Exchange Commission. We assume no obligation to update this presentation, which speaks as of today’s date. Forward-Looking Statements This presentation contains financial measures that differ from the comparable measures under Generally Accepted Accounting Principles (GAAP). Reconciliations between those non-GAAP measures and the comparable GAAP measures are included in the Appendix, or on the page such measure is presented. While management believes the measures are useful to enhance understanding and comparability of our financial results, these non-GAAP measures should not be considered substitutes for the most directly comparable GAAP measures. Additional information concerning non-GAAP measures is included in our periodic filings with the Securities and Exchange Commission that are available in the “Investors – Financials – SEC Filings” section of CNO’s website, CNOinc.com. Non-GAAP Measures IMPORTANT LEGAL INFORMATION

 
3 OUR PURPOSE We secure the future of middle-income America. OUR MISSION We secure the future of middle-income America by providing insurance and financial services that help protect their health, income and retirement needs, while building enduring value for all our stakeholders.

 
4 1 A non-GAAP measure. See the Appendix for a reconciliation to the corresponding GAAP measure. 2 Pre-tax. Operational Highlights  7th consecutive quarter of strong sales momentum – Total new annualized premium (NAP) up 8% – Sales growth in nearly all product categories  Total producing agent count (PAC) up 10%, 5th consecutive quarter of growth  Growth in brokerage and advisory for the 4th consecutive quarter  Recent new product introductions meaningfully contributing to growth Financial Highlights QUARTER IN REVIEW Strong start to 2024, continuing track record of sustainable growth  Operating EPS1 of $0.52 – Favorable total net investment income and insurance product margin, offset by $24.3 million2 of net unfavorable mark-to-market impacts on real estate partnerships within the alternative investment portfolio  New money rate above 6% for the 5th consecutive quarter  Capital and liquidity remain above target levels  Returned $57 million to shareholders  Book value per diluted share excluding AOCI1 was $34.97, up 10%

 
5 1Q 2Q 3Q 4Q FY 1Q vs 1Q23 New Annualized Premiums1 $96.6 $98.7 $98.3 $96.1 $389.7 $104.5 8.2% Consumer 85.7 85.6 83.1 81.8 336.2 91.5 6.8% Worksite 10.9 13.1 15.2 14.3 53.5 13.0 19.3% Annuity Collected Premiums $370.9 $401.8 $372.2 $438.3 $1,583.2 $393.3 6.0% Fee Revenue2 $51.3 $29.4 $27.9 $69.0 $177.6 $50.5 -1.6% Policyholder and Client Assets $13,844 $14,272 $14,357 $14,804 -- $15,169 9.6% Annuity Account Values 11,234 11,344 11,452 11,636 -- 11,723 4.4% Client Assets in BD and Advisory 3 2,610 2,928 2,905 3,168 -- 3,446 32.0% Producing Agent Counts 4,273 4,589 4,588 4,573 -- 4,690 9.8% Consumer 3,985 4,279 4,267 4,224 -- 4,322 8.5% Worksite 288 310 321 349 -- 368 27.8% Average Book Value of Investments & Cash $26,802 $26,900 $27,288 $27,649 -- $27,897 4.1% Average Yield on Allocated Investments 4.62% 4.65% 4.69% 4.68% 4.66% 4.70% 8 bps New Money Rate 6.34% 6.32% 6.03% 6.92% -- 6.17% -17 bps Book Value per Diluted Share x AOCI $31.82 $32.34 $33.75 $33.94 -- $34.97 9.9% 2-year CAGR 13.5% 13.9% 14.6% 12.4% -- 11.1% -- IN V E S T M E N T S & C A P IT A L Change2023 P R O D U C T IO N D IS T R IB U T IO N 2024 1 Measured as 100% of new life and health annualized premiums, except for single premium whole life deposits, which are measured at 10% of annualized premium. 2 Represents fee revenue from the sales of third-party insurance products; fees generated by our broker-dealer and registered investment advisor; fee revenue earned by Optavise. 3 Client assets include cash and securities in brokerage, broker/dealer customer account assets custodied directly at fund companies and insurance carriers, and assets under management in advisory accounts. GROWTH SCORECARD Expanded scorecard demonstrates sustained results across 3 core areas (dollars in millions)

 
61 A non-GAAP measure. See the Appendix for a reconciliation to the corresponding GAAP measure. CONSUMER DIVISION UPDATE Strong execution delivering consistent and sustainable sales growth; 6th consecutive quarter of sales growth  PAC up 8%, 5th consecutive quarter of growth  Recruiting up 12%, 7th consecutive quarter of growth  Disciplined and opportunistic approach to D2C advertising spend  NAP generated from web/digital channels up 13%, now represents ~25% of total D2C  Life and Health NAP up 7%  Health NAP up 22%, Medicare Supplement NAP up 24%, LTC NAP up 71%  Medicare Advantage policies sold up 38%  Annuity collected premium up 6% and account value up 4%  Client assets in brokerage and advisory up 32% to a record $3.4B – New accounts up 8% Operational Highlights Distribution Highlights

 
71 A non-GAAP measure. See the Appendix for a reconciliation to the corresponding GAAP measure. WORKSITE DIVISION UPDATE Insurance sales momentum continuing; 8th consecutive quarter of PAC growth  Life and Health NAP up 19% – At least +15% growth in 7 of the last 8 quarters  New products driving growth – Accident product launched mid-2023, up 43% – Critical Illness product launched 4Q23 is building momentum, up 5%  Fee sales up 9% over prior year  New group clients up 65%  PAC up 28%, first-year PAC up 36% – Proprietary agent referral program continued to drive growth  Continued success with geographic expansion, contributing 40% of NAP growth in the quarter  Investing in technology to modernize the delivery of sales training and development Operational Highlights Distribution Highlights

 
81 A non-GAAP measure. See the Appendix for a reconciliation to the corresponding GAAP measure. $57.5$58.6Net operating income1 110.8114.5 Weighted average shares outstanding (in millions) $0.51 $0.52 Net operating earnings per share1 First Quarter 2024 (dollars in millions, except where noted) Earnings Results FINANCIAL HIGHLIGHTS Solid earnings; Strong underwriting margin and NII allocated to products 1Q23 1Q24  Operating EPS1 of $0.52 — Strong insurance product margins driven by Health and Life — NII allocated to products benefiting from 5 consecutive quarters of NMRs >6% and growing asset base — VII lower due principally to net unfavorable mark-to-market on certain real estate LP investments within our alternative investment portfolio (see slide 12)  Solid free cash flow generation  Strong capital position  $40 million of share repurchases  Operating ROE1 excluding significant items, as adjusted, of 8.5%. As reported Operating ROE1 of 9.7%

 
9 1Q23 2Q23 3Q23 4Q23 1Q24 Annuity $57.3 $57.1 $57.0 $50.7 $52.0 Fixed indexed annuities $46.5 $47.6 $47.2 $41.5 $43.4 Fixed interest annuities $9.1 $8.7 $8.4 $7.7 $7.6 Other annuities $1.7 $0.8 $1.4 $1.5 $1.0 Health $116.5 $108.2 $123.2 $124.1 $123.0 Supplemental health $63.3 $59.9 $62.8 $66.5 $65.4 Medicare supplement $26.1 $32.3 $37.2 $31.9 $26.5 Long-term care $27.1 $16.0 $23.2 $25.7 $31.1 Life $47.4 $57.9 $59.8 $65.9 $54.6 Interest sensitive life $22.8 $24.1 $22.9 $25.0 $22.5 Traditional life $24.6 $33.8 $36.9 $40.9 $32.1 Total Margin $221.2 $223.2 $240.0 $240.7 $229.6 (dollars in millions) Insurance Product Margin Excluding Significant Items1 1 Excludes $12.9 million favorable annuity unlocking, $22.3 million favorable health unlocking and $1.3 million unfavorable life unlocking in 4Q23. See the Appendix for a reconciliation to the corresponding GAAP measure. Annuity margin  Elevated surrenders – due to interest rate environment  FIA – moderating spreads Health margin  Supplemental Health – growth in the block  LTC – favorable benefits and growth in the block Life margin  Traditional Life – growth in the block and lower nondeferrable advertising expense Highlights INSURANCE PRODUCT MARGIN Diverse product portfolio delivers strong underwriting margin

 
10 1 Reflects sum of allocated and non-allocated investment income. Refer to pages 15-18 of the financial supplement for more information on the components of net investment income. 2 Net insurance liabilities for the purpose of allocating investment income to product lines are equal to: (i) policyholder account balances for annuity products; (ii) total reserves before the fair value adjustments reflected in accumulated other comprehensive income (loss), if applicable, for all other products; less (iii) amounts related to reinsurance business; (iv) deferred acquisition costs; (v) the present value of future profits; and (vi) the value of unexpired options credited to insurance liabilities.  Average yield on allocated investments of 4.70% vs. 4.62% in 1Q23  Average net insurance liabilities 2 up 2.3%  New money rate of 6.17%, compared to 6.92% in 4Q23 and 6.34% in 1Q23  Average book value of invested assets up 4.1%; 7th consecutive quarter of book yield increase  Earned yield of 4.06%, compared to 4.49% in 4Q23 and 4.22% in 1Q23  Net unfavorable mark-to-market on real estate partnerships drove $24mm alternative investment loss, below 1Q24 expectation of $14 – $16mm (see slide 12)  Favorable FHLB and FABN margins and asset quality Investment Income Allocated to Product Lines Investment Income Not Allocated to Product Lines Total Net Investment Income1 Annuity Health Life Not allocated $- $100.0 $200.0 $300.0 1Q 2023 1Q 2024 $245.3$235.7 $15.5 $12.3 $- $100.0 $200.0 $300.0 1Q 2023 1Q 2024 $- $100.0 $200.0 $300.0 1Q 2023 1Q 2024 $257.6$251.2 +2.5% INVESTMENT RESULTS NII allocated to products benefiting from strong NMRs and growing asset base; 1Q24 VII below long-term expectation (dollars in millions)

 
11 1 Fair Value as of 3/31/2024 PORTFOLIO COMPOSITION High-quality portfolio driving higher and consistent NII allocated to product Highlights General Approach  Positioned for stable performance across credit cycles  Focus on quality - margin against adverse development  Low impairments through multiple cycles  Embedded asset liability management  Opportunistic investments protect/grow book yield and core earnings power IG Corporates, 42.5% Non-Agency RMBS, 6.2% Mortgage Loans, 7.4% HY Corporates, 2.0% CMBS, 8.7% Municipals, 10.3% ABS, 5.7% Govts/Agency, 3.8% CLO, 4.4% Equities, 0.5% Other, 3.2% Alternatives, 2.5% Policy Loans, 0.5% Cash, 2.5% $26 Billion of Invested Assets1  High degree of liquidity: 60% of portfolio in corporate and government bonds  Up-in-quality positioning over past 12 months — “BBB” allocation reduced by 250 bps — “A” and better allocation increased by 270 bps  Strong credit risk profile — Capital efficient: 97% rated NAIC 1 or 2 — Portfolio average rating A — Significant credit enhancement in structured products including CMBS — Diversified commercial and residential mortgage allocation

 
12 Private Equity, 17% Private Credit, 25% Institutional Real Estate Funds, 20% Real Estate Partnerships, 14% Infrastructure, 7% COLI, 16% Hedge Funds, 1% (dollars in millions) ALTERNATIVES ALLOCATION Book Value LTM Distribution Quarterly Distribution Equity Pickup Private Credit $159 $23 $8 -$2 Institutional Real Estate Funds 129 9 3 -1 Private Equity 110 33 1 2 COLI 100 0 0 0 Real Estate Partnerships 86 11 2 -25 Infrastructure 44 3 0 2 Hedge Fund 4 1 0 0 Total Alternatives $631 $80 $14 -$24 Solid real estate alternative historical performance; Real estate partnerships impacted by net unfavorable mark-to-market in 1Q24; Affected asset base is small and contained Results Real Estate Partnerships  Annual appraisals reflected higher cap rates due to market conditions causing mark-to-market impact  100% leased to IG institutional tenants including notable Fortune 100 companies with long-term, non-cancellable leases  Property level operating performance continues to meet expectations, producing stable cash distributions to CNO  Manageable nominal book value asset base, impacts contained

 
13 Debt to Capital2 Consolidated Risk Based Capital (RBC) Ratio1 Holding Company Liquidity 386% 384% 402% 391% 2021 2022 2023 1Q 2024 $249 $167 $256 $223 2021 2022 2023 1Q24 25.6% 23.4% 23.1% 22.9% 2021 2022 2023 1Q24 1 The ratio of the combined capital of the insurance companies to the minimum amount of capital appropriate to support the overall business operations, as determined based on the methodology developed by the National Association of Insurance Commissioners. 2 Excluding accumulated other comprehensive income (loss) (a non-GAAP measure). See the Appendix for a reconciliation to the corresponding GAAP measure. (dollars in millions)  Target consolidated RBC ratio of approximately 375%  RBC variability expected in periods of market volatility  Target leverage of 25 - 28%  Debt covenant ceiling of 35%  $355 million in debt capacity to top of target leverage range  Target minimum holding company liquidity of $150 million  Liquidity backstopped by $250 million undrawn revolver  No outstanding debt maturities until 2025 CAPITAL AND LIQUIDITY OVERVIEW Capital and liquidity remain above target levels

 
14 Earnings  Operating EPS range of $3.10 - $3.30  18.8% – 19.2% expense ratio  ~23% effective tax rate  $140 – $200 million of excess cash flow to holding company  375% consolidated RBC ratio target  Minimum $150 million in holding company liquidity  Target leverage of 25% – 28% Free Cash Flow / Excess Capital 2024 OUTLOOK No change to guidance Guidance excludes significant items

 
15 4 5 3 2 1 Exclusive focus on underserved middle-income market Significant demographic tailwinds Diverse and integrated "last mile" virtual and in-person model Sustainable growth initiatives in place Strong balance sheet and solid free cash flow generation WHY INVEST IN CNO

 
16 Questions and Answers

 
17  Cash Flow Profile Slide 18  Broker-Dealer/Registered Investment Advisor Slide 19  Expense Ratio Slide 20  New Money Rate Walk Slide 21  New Money Summary Slide 22  Commercial Mortgage Loans Slide 23  Commercial Mortgage-Backed Securities Slide 24  Long-Term Care Insurance Slide 25  Tax Asset Summary Slide 26 Appendix 1: Quarter in Review

 
18 1 Cash flows exclude acquisitions, dividend payments, stock repurchases, and financing transactions. (dollars in millions) 1Q23 1Q24 1Q23 1Q24 Holding Company Cash Flows: Net Dividends (Contributions) from/to Subsidiaries 34.2$ 43.3$ 121.3$ 261.8$ Management Fees 30.2 30.9 121.0 116.8 Surplus Debenture Interest 15.9 17.6 62.7 83.7 Earnings on Corporate Investments 4.3 5.4 11.9 16.1 Other (16.8) (28.5) 0.6 (6.4) Holding Company Sources of Cash 1 67.8 68.7 317.5 472.0 Holding Company Expenses and Other (34.5) (25.8) (79.5) (70.9) Intercompany Tax Receipts (Payments) (3.9) 2.9 (37.2) 35.4 Tax Payments (5.3) (9.5) (14.6) (52.2) Interest Payments (2.1) (2.1) (60.8) (60.8) Excess Cash Flow to Holding Company 1 22.0 34.2 125.4 323.5 Share Repurchases (14.6) (49.8) (94.5) (189.8) Dividend Payments to Stockholders (17.0) (17.3) (65.7) (68.4) Net Change in Holding Company Cash and Investments (9.6) (32.9) (34.8) 65.3 Cash and Investments, Beginning of Period 167.1 255.6 192.3 157.5 Cash and Investments, End of Period 157.5$ 222.8$ 157.5$ 222.8$ For the Quarter Trailing Twelve Months CASH FLOW PROFILE

 
19 Account values up 32% YoY; Record $3.4 billion in client assets 1 Client assets include cash and securities in brokerage, broker/dealer customer account assets custodied directly at fund companies and insurance carriers, and assets under management in advisory accounts. Prior periods have been restated to conform with current presentation. Bankers Life is the marketing brand of various affiliated companies of CNO Financial Group including, Bankers Life and Casualty Company, Bankers Life Securities, Inc., and Bankers Life Advisory Services, Inc. Non-affiliated insurance products are offered through Bankers Life General Agency, Inc. (dba BL General Insurance Agency, Inc., AK, AL, CA, NV, PA). Agents who are financial advisors are registered with Bankers Life Securities, Inc. Securities and variable annuity products and services are offered by Bankers Life Securities, Inc. Member FINRA/SIPC, (dba BL Securities, Inc., AL, GA, IA, IL, MI, NV, PA). Advisory products and services are offered by Bankers Life Advisory Services, Inc. SEC Registered Investment Adviser (dba BL Advisory Services, Inc., AL, GA, IA, MT, NV, PA). Home Office: 303 East Wacker Drive, 5th Floor, Chicago, IL 60601 2 Registered agents are dually licensed as insurance agents and financial representatives who can buy and sell securities for clients, and/or investment advisors who can provide ongoing investment advice for clients. 3 Representative counts represent the average of the last 3 months. (dollars in millions) 2024 1Q 2Q 3Q 4Q 1Q Net New Client Assets in Brokerage 7.9$ (4.2)$ 16.7$ (1.0)$ 10.5$ Brokerage and Advisory1 Advisory 54.2 41.8 47.8 18.7 57.7 Total 62.1$ 37.6$ 64.5$ 17.7$ 68.2$ Client Assets in Brokerage and Brokerage 1,563.5$ 1,626.1$ 1,597.6$ 1,729.8$ 1,855.6$ Advisory1 at end of period Advisory 1,046.6 1,302.0 1,307.6 1,438.2 1,590.4 Total 2,610.1$ 2,928.1$ 2,905.2$ 3,168.0$ 3,446.0$ Registered Agent Counts 2,3 Total 695 695 701 708 710 2023 BROKER-DEALER/REGISTERED INVESTMENT ADVISOR

 
20 2024 1Q 2Q 3Q 4Q 1Q Allocated & Non Allocated Expenses 175.8$ 170.6$ 145.7$ 158.6$ 178.4$ Allocated & Non Allocated Expenses - YTD 175.8 346.4 492.1 650.7 178.4 Significant Items2 -$ -$ (21.7)$ -$ -$ Significant Items - YTD2 - - (21.7) (21.7) - Allocated & Non Allocated Expenses Excluding Significant Items 175.8$ 170.6$ 167.4$ 158.6$ 178.4$ Allocated & Non Allocated Expenses Excluding Significant Items- YTD 175.8 346.4 513.8 672.4 178.4 Policy Income and Net Investment Income Allocated to Products 861.2$ 866.4$ 867.5$ 868.2$ 873.7$ Policy Income and Net Investment Income Allocated to Products - YTD 861.2 1,727.6 2,595.1 3,463.3 873.7 Expense Ratio excluding Significant Items 20.4% 19.7% 19.3% 18.3% 20.4% Expense Ratio excluding Significant Items - YTD 20.4% 20.1% 19.8% 19.4% 20.4% Rolling Twelve Months Ratio 19.7% 19.6% 19.6% 19.4% 19.4% 2023 1 Expenses allocated to products plus not allocated to products, divided by the sum of insurance policy income and net investment income allocated to products. Results exclude significant items. 2 See page 29 for a reconciliation of the significant items. EXPENSE RATIO1 (dollars in millions)

 
21 NEW MONEY RATE WALK 4QNMR Yield Curve Spread Duration Direct Investment 1Q24 NMR 6.92% -0.25% -0.58% -0.15% 0.23% 6.17%

 
22 1Q24 General Account New Money Purchases NEW MONEY SUMMARY $ % GAAP YTM Duration Municipals 204.6 27.2% 5.64% 10.14 IG Corp AAA-A 131.6 17.5% 5.42% 5.26 CLO Debt 67.0 8.9% 5.74% 6.84 Residential Mortgage Loans 61.2 8.1% 6.52% 3.77 ABS 64.8 8.6% 6.83% 3.40 RMBS 56.8 7.6% 5.43% 13.39 Alternatives 54.2 7.2% 8.54% 4.93 IG Corp BBB 53.7 7.1% 6.36% 6.67 CMBS 21.5 2.9% 5.91% 2.44 HY Corp 20.8 2.8% 10.11% 1.58 CRE Loans 12.8 1.7% 5.91% 4.23 EM 2.5 0.3% 5.98% 12.33 Total 751.42 100% 6.17% 6.96 Municipals, 27.2% IG Corp AAA-A, 17.5% CLO Debt, 8.9% Residential Mortgages, 8.1% ABS, 8.6% RMBS, 7.6% Alternatives, 7.2% IG Corp BBB, 7.1% CMBS, 2.9% HY Corporates, 2.8% CRE Loans, 1.7% EM, 0.3% (dollars in millions)

 
23 Our CRE loan portfolio emphasizes lower risk sectors Our CRE loan portfolio is conservatively margined with cushion for adverse development We emphasize stabilized cash flowing properties DSCR Our CRE loan portfolio is not significantly exposed to 2024/2025 maturity default risk (dollars in millions) % o f T o ta l A U M LTV COMMERCIAL MORTGAGE LOANS Apartment, 38.1%, $449.4 Industrial, 26.2%, $308.7Mixed Use, 1.3%, $15.6 Office, 12.1%, $142.3 Other, 7.1%, $83.6 Retail, 15.2%, $178.6 34.8% 18.4% 22.3% 10.6% 7.8% 6.1% 0% 10% 20% 30% 40% <40% 40-50% 50-60% 60-70% 70-80% >80% Prop Type Avg LTV (%) Apartment 51.8 Industrial 43.5 Mixed Use 46.1 Office 60.0 Other 28.6 Retail 42.3 $37.6 $12.3 $53.1 $82.9 2024 2025 2026 2027 M a tu rit ie s ($ m m ) 46.3% 18.4% 23.1% 11.7% 0.5% 0.0% 0% 10% 20% 30% 40% 50% 60% >2.00x 1.70-2.00x 1.40-1.70x 1.15-1.40x 1.00-1.15x <1.00x One delinquent loan in the last 8 years

 
24 Source: NAIC Loss Scenario Our CMBS investments have significant structural cushion for collateral losses Our holdings have limited loss content in severe scenarios Change in CRE Values – NAIC Scenarios BearBull Estimated Life of Portfolio CNO Principal Loss Our CMBS allocation is tilted toward lower risk property types Our CMBS allocation is highly rated - 91% AAA/AA/A categories 73% of our CMBS investments are considered ‘no-loss’ in 2024 NAIC scenario testing Market consistent estimates of collateral losses range from lows of 4% to highs of 8%. 2024 Fed stress test CRE loss rate of 9%. % L o ss A b so rb in g S u b o rd in a tio n in S tr u ct u re (dollars in millions) COMMERCIAL MORTGAGE-BACKED SECURITIES AAA, $1,794 AA+, $71 AA, $43 AA-, $99 A+, $100 A, $101 A-, $60 BBB+, $47 BBB, $91 BBB-, $12 BB, $67 11% 17% 22% 50% <10 10-15 15-30 >30 CNO Index Multifamily Office Other Industrial Retail Hotel 6.6 8.2 9.2 13.0 18.6 22.2 26.0 32.5 10% 6% -1% -10% -19% -24% -29% -40%

 
25 New sales (~$40 million annually) focused on short duration products  Recent growth due to launch of new LTC Fundamental product  99% of new sales for policies with 2 years or less in benefits  Average benefit period of 12 months  New business 25% reinsured since 2008 Reserve assumptions informed by historical experience  No morbidity improvement  No mortality improvement  Minimal future rate increases Favorable economic profile  Total LTC is just 13.2% of overall CNO insurance liabilities  Downside risk significantly reduced after 2018 reinsurance transaction  Average maximum benefit at issuance is $163 per day for inforce block Block highlights  Less than 25% of policies have inflation benefits  2.3% of policies have lifetime benefits, the median benefit period is 1 year, and average non-lifetime benefit period is ~1.5 years  Average attained age is 74.2 years Highly differentiated inforce block; Prudently managed LONG-TERM CARE INSURANCE

 
26 Value of NOLs Details  Effective January 1, 2024, the Company changed its method of accounting for indirect costs allocable to self-constructed real estate assets. This method change will result in a current year deduction of certain costs previously capitalized under the prior method. As a result, the Company recognized a loss of $987 million in the first quarter of 2024 for tax reporting purposes. In 2024, the loss will offset 100% of non-life taxable income and 35% of life taxable income. Any remaining loss after 2024 can be carried forward indefinitely but will be limited each year to 80% of non- life taxable income and 35% of life taxable income pursuant to tax regulations.  Remaining non-life NOLs with expiration dates ranging from 2026 through 2035 are expected to be fully utilized and can offset 100% of non-life taxable income and 35% of life taxable income.  Total estimated economic value of tax assets related to our NOLs and tax strategy of approximately $213 million @ 10% discount rate ($1.94 on a per share basis). $311 (dollars in millions) $311 million / $2.83 per diluted share value of remaining NOLs Non-Life NOLs with Expiration Dates (2026-2035) $77 2024 Non-Life Tax Loss $234 TAX ASSET SUMMARY AS OF MARCH 31, 2024

 
27 Appendix 2: Financial Exhibits Non-GAAP Financial Measures Slides 28 - 43

 
28 Insurance product margin Annuity 63.6$ (12.9)$ (1) 50.7$ Health 146.4 (22.3) (1) 124.1 Life 64.6 1.3 (1) 65.9 Total insurance product margin 274.6 (33.9) 240.7 Allocated expenses (138.8) - (138.8) Income from insurance products 135.8 (33.9) 101.9 Fee income 17.8 - 17.8 Investment income not allocated to product lines 38.3 - 38.3 Expenses not allocated to product lines (19.8) - (19.8) Operating earnings before taxes 172.1 (33.9) 138.2 Income tax (expense) benefit on operating income (38.2) 7.5 (30.7) Net operating income (2) 133.9$ (26.4)$ 107.5$ Net operating income per diluted share (2) 1.18$ 0.23$ 0.95$ Three months ended December 31, 2023 Actual results Significant items Excluding significant items (dollars in millions, except per-share amounts) (1) Impacts arising from our comprehensive annual actuarial review. (2) A non-GAAP measure. See pages 32 and 34 for a reconciliation to the corresponding GAAP measure. The table below summarizes the financial impact of significant items on our 4Q23 net operating income. Management believes that identifying the impact of these items enhances the understanding of our operating results. 4Q23 SIGNIFICANT ITEMS

 
29 Insurance product margin Annuity 57.0$ -$ 57.0$ Health 123.2 - 123.2 Life 59.8 - 59.8 Total insurance product margin 240.0 - 240.0 Allocated expenses (153.2) - (153.2) Income from insurance products 86.8 - 86.8 Fee income (2.9) - (2.9) Investment income not allocated to product lines 38.4 - 38.4 Expenses not allocated to product lines 7.5 (21.7) (1) (14.2) Operating earnings before taxes 129.8 (21.7) 108.1 Income tax (expense) benefit on operating income (28.5) 4.8 (23.7) Net operating income (2) 101.3$ (16.9)$ 84.4$ Net operating income per diluted share (2) 0.88$ (0.14)$ 0.74$ Three months ended September 30, 2023 Actual results Significant items Excluding significant items (dollars in millions, except per-share amounts) (1) Comprised of $21.7 million of legal recoveries, net of expenses and increased legal accruals. (2) A non-GAAP measure. See pages 32 and 34 for a reconciliation to the corresponding GAAP measure. The table below summarizes the financial impact of significant items on our 3Q23 net operating income. Management believes that identifying the impact of these items enhances the understanding of our operating results. 3Q23 SIGNIFICANT ITEMS

 
30 Insurance product margin Annuity 50.8$ 3.2$ (1) 54.0$ Health 140.4 (18.3) (1) 122.1 Life 43.3 14.4 (1) 57.7 Total insurance product margin 234.5 (0.7) 233.8 Allocated expenses (149.1) - (149.1) Income from insurance products 85.4 (0.7) 84.7 Fee income 9.2 - 9.2 Investment income not allocated to product lines 25.2 - 25.2 Expenses not allocated to product lines (12.8) (12.8) Operating earnings before taxes 107.0 (0.7) 106.3 Income tax (expense) benefit on operating income (24.1) 0.2 (23.9) Net operating income (2) 82.9$ (0.5)$ 82.4$ Net operating income per diluted share (2) 0.71$ -$ 0.71$ Three months ended December 31, 2022 Actual results Significant items Excluding significant items (dollars in millions, except per-share amounts) (1) Impacts arising from our comprehensive annual actuarial review. (2) A non-GAAP measure. See pages 32 and 34 for a reconciliation to the corresponding GAAP measure. The table below summarizes the financial impact of significant items on our 4Q22 net operating income. Management believes that identifying the impact of these items enhances the understanding of our operating results. 4Q22 SIGNIFICANT ITEMS

 
31 Insurance product margin Annuity 60.1$ -$ 60.1$ Health 125.4 - 125.4 Life 70.2 - 70.2 Total insurance product margin 255.7 - 255.7 Allocated expenses (152.2) - (152.2) Income from insurance products 103.5 - 103.5 Fee income 3.2 - 3.2 Investment income not allocated to product lines 64.6 - 64.6 Expenses not allocated to product lines 2.9 (22.5) (1) (19.6) Operating earnings before taxes 174.2 (22.5) 151.7 Income tax (expense) benefit on operating income (39.1) 5.1 (34.0) Net operating income (2) 135.1$ (17.4)$ 117.7$ Net operating income per diluted share (2) 1.15$ (0.15)$ 1.00$ Three months ended June 30, 2022 Actual results Significant items Excluding significant items (dollars in millions, except per-share amounts) (1) Comprised of an experience refund of $22.5 million related to a reinsurance agreement. (2) A non-GAAP measure. See pages 32 and 34 for a reconciliation to the corresponding GAAP measure. The table below summarizes the financial impact of significant items on our 2Q22 net operating income. Management believes that identifying the impact of these items enhances the understanding of our operating results. 2Q22 SIGNIFICANT ITEMS

 
32 (dollars in millions) * Management believes that an analysis of Net income applicable to common stock before: (i) net realized investment gains or losses from sales, impairments and change in allowance for credit losses, net of taxes; (ii) net change in market value of investments recognized in earnings, net of taxes; (iii) changes in fair value of embedded derivative liabilities and market risk benefits related to our fixed indexed annuities, net of taxes; (iv) fair value changes related to the agent deferred compensation plan, net of taxes; (v) loss related to reinsurance transactions, net of taxes; (vi) loss on extinguishment of debt, net of taxes; (vii) changes in the valuation allowance for deferred tax assets and other tax items; and (viii) other non-operating items consisting primarily of earnings attributable to variable interest entities, net of taxes ("Net operating income," a non-GAAP financial measure) is important to evaluate the financial performance of the company, and is a key measure commonly used in the life insurance industry. The income tax expense or benefit allocated to the items included in net non-operating income (loss) represents the current and deferred income tax expense or benefit allocated to the items included in non-operating earnings. Management uses this measure to evaluate performance because the items excluded from net operating income can be affected by events that are unrelated to the company's underlying fundamentals. A reconciliation of Net operating income to Net income applicable to common stock is provided in the above table. 1Q23 2Q23 3Q23 4Q23 1Q24 Insurance product margin Annuity 57.3$ 57.1$ 57.0$ 63.6$ 52.0$ Health 116.5 108.2 123.2 146.4 123.0 Life 47.4 57.9 59.8 64.6 54.6 Total insurance product margin 221.2 223.2 240.0 274.6 229.6 Allocated expenses (157.5) (149.5) (153.2) (138.8) (161.6) Income from insurance products 63.7 73.7 86.8 135.8 68.0 Fee income 15.5 0.6 (2.9) 17.8 11.3 Investment income not allocated to product lines 15.5 28.0 38.4 38.3 12.3 Expenses not allocated to product lines (18.3) (21.1) 7.5 (19.8) (16.8) Operating earnings before taxes 76.4 81.2 129.8 172.1 74.8 Income tax expense on operating income (17.8) (18.9) (28.5) (38.2) (17.3) Net operating income* 58.6 62.3 101.3 133.9 57.5 Net realized investment gains (losses) from sales, impairments and change in allowance for credit losses (12.7) (31.3) (20.1) 1.4 (4.6) Net change in market value of investments recognized in earnings (1.9) (4.0) (9.2) 8.8 12.4 Changes in fair value of embedded derivative liabilities and market risk benefits (65.1) 50.4 109.4 (124.6) 64.0 Fair value changes related to agent deferred compensation plan - - 6.8 (10.3) - Other 2.3 (0.2) (1.1) (1.3) (0.4) Non-operating income (loss) before taxes (77.4) 14.9 85.8 (126.0) 71.4 Income tax (expense) benefit on non-operating income (loss) 18.0 (3.5) (19.8) 28.4 (16.6) Net non-operating income (loss) (59.4) 11.4 66.0 (97.6) 54.8 Net income (loss) (0.8)$ 73.7$ 167.3$ 36.3$ 112.3$ QUARTERLY EARNINGS

 
33 The following provides additional information regarding certain non-GAAP measures used in this presentation. A non-GAAP measure is a numerical measure of a company’s performance, financial position, or cash flows that excludes or includes amounts that are normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. While management believes these measures are useful to enhance understanding and comparability of our financial results, these non-GAAP measures should not be considered as substitutes for the most directly comparable GAAP measures. Additional information concerning non-GAAP measures is included in our periodic filings with the Securities and Exchange Commission that are available in the “Investors – SEC Filings” section of CNO’s website, www.CNOinc.com. Operating earnings measures Management believes that an analysis of net income applicable to common stock before net realized investment gains or losses from sales, impairments and change in allowance for credit losses, net change in market value of investments recognized in earnings, changes in fair value of embedded derivative liabilities and market risk benefits related to our fixed indexed annuities, fair value changes related to the agent deferred compensation plan, loss on extinguishment of debt, changes in the valuation allowance for deferred tax assets and other tax items and other non-operating items consisting primarily of earnings attributable to variable interest entities (“net operating income,” a non- GAAP financial measure) is important to evaluate the financial performance of the Company and is a key measure commonly used in the life insurance industry. Management uses this measure to evaluate performance because the items excluded from net operating income can be affected by events that are unrelated to the Company’s underlying fundamentals. INFORMATION RELATED TO CERTAIN NON-GAAP FINANCIAL MEASURES

 
34 A reconciliation of net income applicable to common stock to net operating income (and related per-share amounts) is as follows: (dollars in millions, except per-share amounts) 1Q23 2Q23 3Q23 4Q23 1Q24 Net income (loss) applicable to common stock (0.8)$ 73.7$ 167.3$ 36.3$ 112.3$ Non-operating items: Net realized investment (gains) losses from sales and impairments 12.7 31.3 20.1 (1.4) 4.6 Net change in market value of investments recognized in earnings 1.9 4.0 9.2 (8.8) (12.4) Changes in fair value of embedded derivative liabilities and market risk benefits 65.1 (50.4) (109.4) 124.6 (64.0) Fair value changes related to the agent deferred compensation plan - - (6.8) 10.3 - Other (2.3) 0.2 1.1 1.3 0.4 Non-operating (income) loss before taxes 77.4 (14.9) (85.8) 126.0 (71.4) Income tax expense (benefit) on non-operating income (18.0) 3.5 19.8 (28.4) 16.6 Net non-operating (income) loss 59.4 (11.4) (66.0) 97.6 (54.8) Net operating income (a non-GAAP financial measure) 58.6$ 62.3$ 101.3$ 133.9$ 57.5$ Per diluted share: Net income (loss) (0.01)$ 0.64$ 1.46$ 0.32$ 1.01$ Net realized investment (gains) losses from sales and impairments (net of taxes) 0.09 0.21 0.14 (0.01) 0.03 Net change in market value of investments recognized in earnings (net of taxes) 0.01 0.02 0.06 (0.06) (0.08) Changes in fair value of embedded derivative liabilities and market risk benefits (net of taxes) 0.44 (0.33) (0.74) 0.85 (0.44) Fair value changes related to the agent deferred compensation plan (net of taxes) - - (0.05) 0.07 - Other (0.02) - 0.01 0.01 - Net operating income (a non-GAAP financial measure) 0.51$ 0.54$ 0.88$ 1.18$ 0.52$ INFORMATION RELATED TO CERTAIN NON-GAAP FINANCIAL MEASURES

 
35 A reconciliation of operating income and shares used to calculate basic and diluted operating earnings per share is as follows: (dollars in millions, except per-share amounts, and shares in thousands) 1Q23 2Q23 3Q23 4Q23 1Q24 Operating income 58.6$ 62.3$ 101.3$ 133.9$ 57.5$ Weighted average shares outstanding for basic earnings per share 114,545 114,273 112,689 111,590 108,964 Effect of dilutive securities on weighted average shares: Stock options, restricted stock and performance units - 1,377 1,773 2,067 1,881 Weighted average shares outstanding for diluted earnings per share 114,545 115,650 114,462 113,657 110,845 Net operating income per diluted share 0.51$ 0.54$ 0.88$ 1.18$ 0.52$ (a) (a) Equivalent common shares of 2,182.5 were not included in the diluted weighted average shares outstanding due to the net loss recognized in 1Q23. INFORMATION RELATED TO CERTAIN NON-GAAP FINANCIAL MEASURES

 
36 Book value per diluted share Book value per diluted share reflects the potential dilution that could occur if outstanding stock options were exercised, restricted stock and performance units were vested, and convertible securities were converted. The dilution from options, restricted shares and performance units is calculated using the treasury stock method. Under this method, we assume the proceeds from the exercise of the options (or the unrecognized compensation expense with respect to restricted stock and performance units) will be used to purchase shares of our common stock at the closing market price on the last day of the period. In addition, the calculation of this non-GAAP measure differs from the corresponding GAAP measure because accumulated other comprehensive income (loss) has been excluded from the value of capital used to determine this measure. Management believes this non-GAAP measure is useful because it removes the volatility that arises from changes in the unrealized appreciation (depreciation) of our investments. A reconciliation from book value per share to book value per diluted share, excluding accumulated other comprehensive income (loss) is as follows: (dollars in millions, except share and per-share amounts) 1Q23 2Q23 3Q23 4Q23 1Q24 Total shareholders' equity 2,031.8$ 1,995.8$ 1,890.1$ 2,215.6$ 2,367.7$ Shares outstanding for the period 114,905,172 113,673,882 112,163,169 109,357,540 108,568,594 Book value per share 17.68$ 17.56$ 16.85$ 20.26$ 21.81$ Total shareholders' equity 2,031.8$ 1,995.8$ 1,890.1$ 2,215.6$ 2,367.7$ Accumulated other comprehensive loss (1,664.4) (1,733.5) (1,956.7) (1,576.8) (1,480.3) Adjusted shareholders' equity excluding AOCI 3,696.2$ 3,729.3$ 3,846.8$ 3,792.4$ 3,848.0$ Shares outstanding for the period 114,905,172 113,673,882 112,163,169 109,357,540 108,568,594 Dilutive common stock equivalents related to: Stock options, restricted stock and performance units 1,270,836 1,629,412 1,811,501 2,392,716 1,467,901 Diluted shares outstanding 116,176,008 115,303,294 113,974,670 111,750,256 110,036,495 Book value per diluted share (a non-GAAP measure) 31.82$ 32.34$ 33.75$ 33.94$ 34.97$ INFORMATION RELATED TO CERTAIN NON-GAAP FINANCIAL MEASURES

 
37 Operating return measures Management believes that an analysis of net income applicable to common stock before net realized investment gains or losses from sales, impairments and change in allowance for credit losses, net change in market value of investments recognized in earnings, changes in fair value of embedded derivative liabilities and market risk benefits related to our fixed indexed annuities, fair value changes related to the agent deferred compensation plan, changes in the valuation allowance for deferred tax assets and other tax items, loss on extinguishment of debt and other non-operating items consisting primarily of earnings attributable to variable interest entities (“net operating income,” a non-GAAP financial measure) is important to evaluate the financial performance of the Company and is a key measure commonly used in the life insurance industry. Management uses this measure to evaluate performance because the items excluded from net operating income can be affected by events that are unrelated to the Company’s underlying fundamentals. Management also believes that an operating return, excluding significant items, is important as the impact of these items enhances the understanding of our operating results. This non-GAAP financial measure also differs from return on equity because accumulated other comprehensive income (loss) has been excluded from the value of equity used to determine this ratio. Management believes this non-GAAP financial measure is useful because it removes the volatility that arises from changes in accumulated other comprehensive income (loss). Such volatility is often caused by changes in the estimated fair value of our investment portfolio resulting from changes in general market interest rates rather than the business decisions made by management. In addition, our equity includes the value of significant net operating loss carryforwards (included in income tax assets). In accordance with GAAP, these assets are not discounted, and accordingly will not provide a return to shareholders (until after it is realized as a reduction to taxes that would otherwise be paid). Management believes that excluding this value from the equity component of this measure enhances the understanding of the effect these non-discounted assets have on operating returns and the comparability of these measures from period-to-period. Operating return measures are used in measuring the performance of our business units and are used as a basis for incentive compensation. INFORMATION RELATED TO CERTAIN NON-GAAP FINANCIAL MEASURES

 
38 The calculations of: (i) operating return on equity, excluding accumulated other comprehensive income (loss) and net operating loss carryforwards (a non-GAAP financial measure); (ii) operating return, excluding significant item, on equity, excluding accumulated other comprehensive income (loss) and net operating loss carryforwards (a non- GAAP financial measure); and (iii) return on equity are as follows: (dollars in millions) (Continued on next page) 1Q23 2Q23 3Q23 4Q23 1Q24 Operating income 354.5$ 281.7$ 305.1$ 356.1$ 355.0$ Operating income, excluding significant items 336.6$ 281.2$ 287.7$ 312.8$ 311.7$ Net income 446.4$ 286.8$ 278.2$ 276.5$ 389.6$ Average common equity, excluding accumulated other comprehensive income (loss) and net operating loss carryforwards (a non-GAAP financial measure) 3,434.8$ 3,519.3$ 3,582.8$ 3,631.5$ 3,650.0$ Average common shareholders' equity 2,046.3$ 1,931.5$ 1,918.3$ 1,977.5$ 2,075.3$ Operating return on equity, excluding accumulated other comprehensive income (loss) and net operating loss carryforwards (a non-GAAP financial measure) 10.3% 8.0% 8.5% 9.8% 9.7% Operating return, excluding significant items, on equity, excluding accumulated other comprehensive income (loss) and net operating loss carryforwards (a non-GAAP financial measure) 9.8% 8.0% 8.0% 8.6% 8.5% Return on equity 21.8% 14.8% 14.5% 14.0% 18.8% Twelve Months Ended INFORMATION RELATED TO CERTAIN NON-GAAP FINANCIAL MEASURES

 
39 The following summarizes: (i) operating earnings; (ii) significant items; (iii) operating earnings, excluding significant items; and (iv) net income (loss): (dollars in millions) (a) The significant items have been discussed in either the current or prior press releases. (Continued on next page) Net operating income Significant items (a) Net operating income, excluding significant items Net operating income, excluding significant items - trailing four quarters Net income (loss) Net income - trailing four quarters 2Q22 135.1$ (17.4)$ 117.7$ 292.6$ 233.3$ 520.1$ 3Q22 77.9 - 77.9 260.1 175.9 592.6 4Q22 82.9 (0.5) 82.4 342.5 38.0 630.6 1Q23 58.6 - 58.6 336.6 (0.8) 446.4 2Q23 62.3 - 62.3 281.2 73.7 286.8 3Q23 101.3 (16.9) 84.4 287.7 167.3 278.2 4Q23 133.9 (26.4) 107.5 312.8 36.3 276.5 1Q24 57.5 - 57.5 311.7 112.3 389.6 INFORMATION RELATED TO CERTAIN NON-GAAP FINANCIAL MEASURES

 
40 The calculations of: (i) operating return on equity, excluding accumulated other comprehensive income (loss) and net operating loss carryforwards (a non-GAAP financial measure); (ii) operating return, excluding significant item, on equity, excluding accumulated other comprehensive income (loss) and net operating loss carryforwards (a non- GAAP financial measure); and (iii) return on equity are as follows: (dollars in millions) (Continued on next page) 1Q23 2Q23 3Q23 4Q23 1Q24 Pre-tax operating earnings (a non-GAAP financial measure) 458.6$ 365.6$ 394.4$ 459.5$ 457.9$ Income tax expense (104.1) (83.9) (89.3) (103.4) (102.9) Operating return 354.5 281.7 305.1 356.1 355.0 Non-operating items: Net realized investment losses from sales and impairments (67.7) (71.9) (91.3) (62.7) (54.6) Net change in market value of investments recognized in earnings (49.6) (31.9) (24.1) (6.3) 8.0 Changes in fair value of embedded derivative liabilities and market risk benefits 209.7 99.5 78.3 (29.9) 99.2 Fair value changes and amendment related to the agent deferred compensation plan 26.2 12.2 7.0 (3.5) (3.5) Other (2.0) (2.0) (5.1) (0.3) (3.0) Non-operating income (loss) before taxes 116.6 5.9 (35.2) (102.7) 46.1 Income tax (expense) benefit on non-operating income (loss) (24.7) (0.8) 8.3 23.1 (11.5) Net non-operating income (loss) 91.9 5.1 (26.9) (79.6) 34.6 Net income 446.4$ 286.8$ 278.2$ 276.5$ 389.6$ Twelve Months Ended INFORMATION RELATED TO CERTAIN NON-GAAP FINANCIAL MEASURES

 
41 A reconciliation of consolidated capital, excluding accumulated other comprehensive income (loss) and net operating loss carryforwards (a non-GAAP financial measure) to common shareholders’ equity, is as follows: (dollars in millions) 1Q22 2Q22 3Q22 4Q22 Consolidated capital, excluding accumulated other comprehensive income (loss) and net operating loss carryforwards (a non-GAAP financial measure) 3,141.7$ 3,329.0$ 3,510.3$ 3,557.1$ Net operating loss carryforwards 238.2 214.7 190.9 169.0 Accumulated other comprehensive loss (561.5) (1,415.8) (1,837.8) (1,957.3) Common shareholders' equity 2,818.4$ 2,127.9$ 1,863.4$ 1,768.8$ 1Q23 2Q23 3Q23 4Q23 Consolidated capital, excluding accumulated other comprehensive income (loss) and net operating loss carryforwards (a non-GAAP financial measure) 3,543.8$ 3,603.0$ 3,744.2$ 3,712.8$ Net operating loss carryforwards 152.4 126.3 102.6 79.6 Accumulated other comprehensive loss (1,664.4) (1,733.5) (1,956.7) (1,576.8) Common shareholders' equity 2,031.8$ 1,995.8$ 1,890.1$ 2,215.6$ 1Q24 Consolidated capital, excluding accumulated other comprehensive income (loss) and net operating loss carryforwards (a non-GAAP financial measure) 3,536.8$ Net operating loss carryforwards 311.2 Accumulated other comprehensive loss (1,480.3) Common shareholders' equity 2,367.7$ INFORMATION RELATED TO CERTAIN NON-GAAP FINANCIAL MEASURES

 
42 A reconciliation of consolidated capital, excluding accumulated other comprehensive income (loss) and net operating loss carryforwards (a non-GAAP financial measure) to common shareholders’ equity, is as follows: (dollars in millions) 1Q23 2Q23 3Q23 4Q23 1Q24 Consolidated capital, excluding accumulated other comprehensive income (loss) and net operating loss carryforwards (a non-GAAP financial measure) 3,434.8$ 3,519.3$ 3,582.8$ 3,631.5$ 3,650.0$ Net operating loss carryforwards 192.5 170.7 148.6 126.4 135.1 Accumulated other comprehensive loss (1,581.0) (1,758.5) (1,813.1) (1,780.4) (1,709.8) Common shareholders' equity 2,046.3$ 1,931.5$ 1,918.3$ 1,977.5$ 2,075.3$ Trailing Four Quarter Average INFORMATION RELATED TO CERTAIN NON-GAAP FINANCIAL MEASURES

 
43 Debt to capital ratio, excluding accumulated other comprehensive income (loss) The debt to capital ratio, excluding accumulated other comprehensive income (loss), differs from the debt to capital ratio because accumulated other comprehensive income (loss) has been excluded from the value of capital used to determine this measure. Management believes this non-GAAP financial measure is useful because it removes the volatility that arises from changes in accumulated other comprehensive income (loss). Such volatility is often caused by changes in the estimated fair value of our investment portfolio resulting from changes in general market interest rates rather than the business decisions made by management. A reconciliation of these ratios is as follows: (dollars in millions) 2021 2022 2023 1Q24 Corporate notes payable 1,137.3$ 1,138.8$ 1,140.5$ 1,141.0$ Total shareholders' equity 3,684.7 1,768.8 2,215.6 2,367.7 Total capital 4,822.0$ 2,907.6$ 3,356.1$ 3,508.7$ Corporate debt to capital 23.6% 39.2% 34.0% 32.5% Corporate notes payable 1,137.3$ 1,138.8$ 1,140.5$ 1,141.0$ Total shareholders' equity 3,684.7 1,768.8 2,215.6 2,367.7 Less accumulated other comprehensive (income) loss (373.7) 1,957.3 1,576.8 1,480.3 Total capital 4,448.3$ 4,864.9$ 4,932.9$ 4,989.0$ Debt to total capital ratio, excluding AOCI (a non-GAAP financial measure) 25.6% 23.4% 23.1% 22.9% INFORMATION RELATED TO CERTAIN NON-GAAP FINANCIAL MEASURES